Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease...
Saved in:
Published in | Allergy (Copenhagen) Vol. 75; no. 7; pp. 1564 - 1581 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Blackwell Publishing Ltd
01.07.2020
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute‐phase reactants, and serum biochemistry in COVID‐19. Similar to many other viral infections, asymptomatic disease is present in a significant but currently unknown fraction of the affected individuals. In the majority of the patients, a 1‐week, self‐limiting viral respiratory disease typically occurs, which ends with the development of neutralizing antiviral T cell and antibody immunity. The IgM‐, IgA‐, and IgG‐type virus‐specific antibodies levels are important measurements to predict population immunity against this disease and whether cross‐reactivity with other coronaviruses is taking place. High viral load during the first infection and repeated exposure to virus especially in healthcare workers can be an important factor for severity of disease. It should be noted that many aspects of severe patients are unique to COVID‐19 and are rarely observed in other respiratory viral infections, such as severe lymphopenia and eosinopenia, extensive pneumonia and lung tissue damage, a cytokine storm leading to acute respiratory distress syndrome, and multiorgan failure. Lymphopenia causes a defect in antiviral and immune regulatory immunity. At the same time, a cytokine storm starts with extensive activation of cytokine‐secreting cells with innate and adaptive immune mechanisms both of which contribute to a poor prognosis. Elevated levels of acute‐phase reactants and lymphopenia are early predictors of high disease severity. Prevention of development to severe disease, cytokine storm, acute respiratory distress syndrome, and novel approaches to prevent their development will be main routes for future research areas. As we learn to live amidst the virus, understanding the immunology of the disease can assist in containing the pandemic and in developing vaccines and medicines to prevent and treat individual patients. |
---|---|
AbstractList | As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID-19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute-phase reactants, and serum biochemistry in COVID-19. Similar to many other viral infections, asymptomatic disease is present in a significant but currently unknown fraction of the affected individuals. In the majority of the patients, a 1-week, self-limiting viral respiratory disease typically occurs, which ends with the development of neutralizing antiviral T cell and antibody immunity. The IgM-, IgA-, and IgG-type virus-specific antibodies levels are important measurements to predict population immunity against this disease and whether cross-reactivity with other coronaviruses is taking place. High viral load during the first infection and repeated exposure to virus especially in healthcare workers can be an important factor for severity of disease. It should be noted that many aspects of severe patients are unique to COVID-19 and are rarely observed in other respiratory viral infections, such as severe lymphopenia and eosinopenia, extensive pneumonia and lung tissue damage, a cytokine storm leading to acute respiratory distress syndrome, and multiorgan failure. Lymphopenia causes a defect in antiviral and immune regulatory immunity. At the same time, a cytokine storm starts with extensive activation of cytokine-secreting cells with innate and adaptive immune mechanisms both of which contribute to a poor prognosis. Elevated levels of acute-phase reactants and lymphopenia are early predictors of high disease severity. Prevention of development to severe disease, cytokine storm, acute respiratory distress syndrome, and novel approaches to prevent their development will be main routes for future research areas. As we learn to live amidst the virus, understanding the immunology of the disease can assist in containing the pandemic and in developing vaccines and medicines to prevent and treat individual patients. Abstract As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus disease 2019 (COVID‐19) appears practically impossible. There is a pressing need to improve our understanding of the immunology of this disease to contain the pandemic by developing vaccines and medicines for the prevention and treatment of patients. In this review, we aim to improve our understanding on the immune response and immunopathological changes in patients linked to deteriorating clinical conditions such as cytokine storm, acute respiratory distress syndrome, autopsy findings and changes in acute‐phase reactants, and serum biochemistry in COVID‐19. Similar to many other viral infections, asymptomatic disease is present in a significant but currently unknown fraction of the affected individuals. In the majority of the patients, a 1‐week, self‐limiting viral respiratory disease typically occurs, which ends with the development of neutralizing antiviral T cell and antibody immunity. The IgM‐, IgA‐, and IgG‐type virus‐specific antibodies levels are important measurements to predict population immunity against this disease and whether cross‐reactivity with other coronaviruses is taking place. High viral load during the first infection and repeated exposure to virus especially in healthcare workers can be an important factor for severity of disease. It should be noted that many aspects of severe patients are unique to COVID‐19 and are rarely observed in other respiratory viral infections, such as severe lymphopenia and eosinopenia, extensive pneumonia and lung tissue damage, a cytokine storm leading to acute respiratory distress syndrome, and multiorgan failure. Lymphopenia causes a defect in antiviral and immune regulatory immunity. At the same time, a cytokine storm starts with extensive activation of cytokine‐secreting cells with innate and adaptive immune mechanisms both of which contribute to a poor prognosis. Elevated levels of acute‐phase reactants and lymphopenia are early predictors of high disease severity. Prevention of development to severe disease, cytokine storm, acute respiratory distress syndrome, and novel approaches to prevent their development will be main routes for future research areas. As we learn to live amidst the virus, understanding the immunology of the disease can assist in containing the pandemic and in developing vaccines and medicines to prevent and treat individual patients. |
Author | Akdis, Cezmi A. Akdis, Mübeccel Veen, Willem Nadeau, Kari O’Mahony, Liam Sokolowska, Milena Gao, Yadong Azkur, Ahmet Kursat Brüggen, Marie‐Charlotte Azkur, Dilek |
AuthorAffiliation | 5 Department of Dermatology University Hospital Zurich Zurich Switzerland 8 Departments of Medicine and Microbiology APC Microbiome Ireland University College Cork Cork Ireland 9 Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China 2 Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland 3 Division of Pediatric Allergy and Immunology Department of Pediatrics Faculty of Medicine University of Kirikkale Kirikkale Turkey 4 Christine Kühne‐Center for Allergy Research and Education Davos Switzerland 6 Faculty of Medicine University Zurich Zurich Switzerland 7 Hochgebirgsklinik Davos Davos Switzerland 1 Department of Virology Faculty of Veterinary Medicine University of Kirikkale Kirikkale Turkey 10 Sean N. Parker Center for Allergy and Asthma Research Stanford University Stanford CA USA |
AuthorAffiliation_xml | – name: 7 Hochgebirgsklinik Davos Davos Switzerland – name: 5 Department of Dermatology University Hospital Zurich Zurich Switzerland – name: 9 Department of Allergology Zhongnan Hospital of Wuhan University Wuhan China – name: 8 Departments of Medicine and Microbiology APC Microbiome Ireland University College Cork Cork Ireland – name: 2 Swiss Institute of Allergy and Asthma Research (SIAF) University of Zurich Davos Switzerland – name: 4 Christine Kühne‐Center for Allergy Research and Education Davos Switzerland – name: 1 Department of Virology Faculty of Veterinary Medicine University of Kirikkale Kirikkale Turkey – name: 3 Division of Pediatric Allergy and Immunology Department of Pediatrics Faculty of Medicine University of Kirikkale Kirikkale Turkey – name: 6 Faculty of Medicine University Zurich Zurich Switzerland – name: 10 Sean N. Parker Center for Allergy and Asthma Research Stanford University Stanford CA USA |
Author_xml | – sequence: 1 givenname: Ahmet Kursat orcidid: 0000-0002-5597-8917 surname: Azkur fullname: Azkur, Ahmet Kursat organization: University of Kirikkale – sequence: 2 givenname: Mübeccel orcidid: 0000-0003-0554-9943 surname: Akdis fullname: Akdis, Mübeccel organization: University of Zurich – sequence: 3 givenname: Dilek orcidid: 0000-0002-4396-9087 surname: Azkur fullname: Azkur, Dilek organization: University of Kirikkale – sequence: 4 givenname: Milena orcidid: 0000-0001-9710-6685 surname: Sokolowska fullname: Sokolowska, Milena organization: University of Zurich – sequence: 5 givenname: Willem surname: Veen fullname: Veen, Willem organization: University of Zurich – sequence: 6 givenname: Marie‐Charlotte surname: Brüggen fullname: Brüggen, Marie‐Charlotte organization: Hochgebirgsklinik Davos – sequence: 7 givenname: Liam orcidid: 0000-0003-4705-3583 surname: O’Mahony fullname: O’Mahony, Liam organization: University College Cork – sequence: 8 givenname: Yadong orcidid: 0000-0003-1251-7608 surname: Gao fullname: Gao, Yadong organization: Zhongnan Hospital of Wuhan University – sequence: 9 givenname: Kari orcidid: 0000-0002-2146-2955 surname: Nadeau fullname: Nadeau, Kari organization: Stanford University – sequence: 10 givenname: Cezmi A. orcidid: 0000-0001-8020-019X surname: Akdis fullname: Akdis, Cezmi A. email: akdisac@siaf.uzh.ch organization: Christine Kühne‐Center for Allergy Research and Education |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32396996$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctOGzEUhi0EgkC76AtUlrqBxYCvM-NNpSjlEikSErdVJcsxZxIjjx3GGSp2fYQ-I0-CQwDRSvXCXpzvfDrH_y7aDDEAQl8oOaT5HBnvD6ngpdhAA8pVXSil5CYaEEpkISSvd9BuSneEkIopso12OOOqVKocoJ_jtu0D4A7SIoYEeBnx5fDi8un3n1G8yTfDJtziFuzcBJfahGOD3aonLsxyHn2cOWs8XpVnkLALeHR-M_6RO6n6hLYa4xN8fn330PXJ8dXorJicn45Hw0lhJVGiqE3F6wpESUleQlWGCTqVtpxaq4CJEhSAhLqqbE2FAiNrS5upbbhqyoZbyffQ97V30U9buLUQlp3xetG51nSPOhqn_64EN9ez-KArlj9E1Fmw_yro4n0Paalblyx4bwLEPmkmCBNMSsEy-u0f9C72XcjrZYoxwUUlSaYO1pTtYkodNO_DUKJXmemcmX7JLLNfP07_Tr6FlIGjNfDLeXj8v0kPJ5O18hnNEKRo |
CitedBy_id | crossref_primary_10_1186_s40794_023_00201_0 crossref_primary_10_1371_journal_pone_0247797 crossref_primary_10_3724_abbs_2022071 crossref_primary_10_1080_19390211_2020_1834047 crossref_primary_10_33808_clinexphealthsci_1135762 crossref_primary_10_1016_j_vacun_2021_09_003 crossref_primary_10_1111_all_14523 crossref_primary_10_3389_fimmu_2021_656350 crossref_primary_10_3390_covid3120118 crossref_primary_10_1007_s12250_020_00265_8 crossref_primary_10_1186_s43054_022_00105_2 crossref_primary_10_1111_all_14647 crossref_primary_10_3390_biom11050694 crossref_primary_10_3390_jpm11121328 crossref_primary_10_1016_j_ijbiomac_2020_09_204 crossref_primary_10_3390_immuno3010007 crossref_primary_10_1542_hpeds_2020_003517 crossref_primary_10_1016_j_heliyon_2024_e33237 crossref_primary_10_1016_j_intimp_2021_107571 crossref_primary_10_1080_08830185_2021_1929205 crossref_primary_10_1111_tbed_13931 crossref_primary_10_3390_biomedicines10030549 crossref_primary_10_3390_vaccines9121402 crossref_primary_10_35366_98225 crossref_primary_10_3390_jcm10204798 crossref_primary_10_3389_fimmu_2022_978619 crossref_primary_10_1016_j_genrep_2022_101497 crossref_primary_10_34108_eujhs_1042777 crossref_primary_10_1111_all_14657 crossref_primary_10_1007_s00289_022_04579_3 crossref_primary_10_1016_j_nutres_2021_05_008 crossref_primary_10_1136_bmjresp_2020_000731 crossref_primary_10_1016_j_arbres_2020_08_007 crossref_primary_10_1080_19490976_2023_2223340 crossref_primary_10_1111_ijcp_14752 crossref_primary_10_1016_j_acra_2021_01_022 crossref_primary_10_1039_D1TB00674F crossref_primary_10_1016_j_clispe_2023_100028 crossref_primary_10_1128_spectrum_03075_22 crossref_primary_10_1016_j_autrev_2021_102865 crossref_primary_10_18499_2225_7357_2020_9_3_72_85 crossref_primary_10_1016_j_intimp_2021_107586 crossref_primary_10_2139_ssrn_3704738 crossref_primary_10_3389_fimmu_2021_748103 crossref_primary_10_3390_ijms222313009 crossref_primary_10_2147_IJN_S341890 crossref_primary_10_3389_fmed_2021_629112 crossref_primary_10_1155_2021_9101082 crossref_primary_10_1590_1414_431x202010725 crossref_primary_10_1186_s12879_023_08971_w crossref_primary_10_3389_fpubh_2022_1069898 crossref_primary_10_1155_2020_2914275 crossref_primary_10_1080_14740338_2023_2205638 crossref_primary_10_1093_femsre_fuab035 crossref_primary_10_1155_2022_5589089 crossref_primary_10_3390_cells11142198 crossref_primary_10_1111_all_14545 crossref_primary_10_3390_ijms22041737 crossref_primary_10_1111_all_14429 crossref_primary_10_1111_ijcp_14843 crossref_primary_10_29262_ram_v67i4_828 crossref_primary_10_3390_life12020153 crossref_primary_10_3389_fimmu_2022_1030238 crossref_primary_10_7554_eLife_60122 crossref_primary_10_1016_j_dialog_2022_100022 crossref_primary_10_29001_2073_8552_2022_37_4_63_69 crossref_primary_10_1016_j_ijid_2021_01_031 crossref_primary_10_1016_j_jim_2023_113556 crossref_primary_10_2174_1381612829666221024154951 crossref_primary_10_1016_j_metop_2021_100103 crossref_primary_10_1155_2022_3012778 crossref_primary_10_1007_s12035_023_03803_z crossref_primary_10_1051_e3sconf_202450902005 crossref_primary_10_3390_vaccines11020432 crossref_primary_10_1016_j_biopha_2022_113368 crossref_primary_10_1186_s12890_021_01592_6 crossref_primary_10_1007_s11010_022_04487_0 crossref_primary_10_29089_paom_153600 crossref_primary_10_3390_jpm12060995 crossref_primary_10_3390_pathogens12020184 crossref_primary_10_3390_genes14020407 crossref_primary_10_1016_j_biocel_2021_106114 crossref_primary_10_3389_fpubh_2022_914193 crossref_primary_10_1007_s11845_021_02522_5 crossref_primary_10_1016_j_obmed_2023_100493 crossref_primary_10_1186_s12967_020_02456_z crossref_primary_10_1002_ajh_25877 crossref_primary_10_1007_s10753_022_01651_y crossref_primary_10_1007_s00281_020_00818_9 crossref_primary_10_2217_fvl_2022_0172 crossref_primary_10_3390_diagnostics11030537 crossref_primary_10_1007_s12038_020_00067_w crossref_primary_10_1007_s40121_021_00423_9 crossref_primary_10_1016_j_jksus_2024_103176 crossref_primary_10_1111_all_14687 crossref_primary_10_3389_fphar_2021_670170 crossref_primary_10_3390_v16030370 crossref_primary_10_1016_j_clnesp_2023_04_022 crossref_primary_10_1111_all_14449 crossref_primary_10_1186_s13054_020_03138_4 crossref_primary_10_3390_vaccines12050459 crossref_primary_10_21508_1027_4065_2022_67_2_142_152 crossref_primary_10_1007_s11356_022_20984_7 crossref_primary_10_3390_ijerph19053111 crossref_primary_10_1111_aor_13864 crossref_primary_10_3390_diagnostics10070453 crossref_primary_10_1126_science_adg7942 crossref_primary_10_1055_s_0041_1722919 crossref_primary_10_15690_vramn1410 crossref_primary_10_1002_ajhb_23478 crossref_primary_10_1002_jmv_26809 crossref_primary_10_1007_s12026_022_09265_0 crossref_primary_10_17816_mechnikov629636 crossref_primary_10_1038_s41598_022_23143_7 crossref_primary_10_1111_all_15663 crossref_primary_10_7759_cureus_40556 crossref_primary_10_3389_fnut_2022_887378 crossref_primary_10_1557_s43579_021_00146_5 crossref_primary_10_3389_fimmu_2020_01642 crossref_primary_10_1126_scitranslmed_abd5487 crossref_primary_10_1155_2023_1995642 crossref_primary_10_1016_j_meegid_2021_104892 crossref_primary_10_29235_1814_6023_2021_18_4_497_512 crossref_primary_10_1097_MRM_0000000000000306 crossref_primary_10_7759_cureus_48046 crossref_primary_10_1016_j_ajpath_2020_06_010 crossref_primary_10_3390_ph16010130 crossref_primary_10_58838_2075_1230_2024_102_1_26_33 crossref_primary_10_1080_21505594_2021_1911477 crossref_primary_10_1109_JSEN_2021_3089016 crossref_primary_10_1007_s10495_022_01754_9 crossref_primary_10_1186_s12879_023_08556_7 crossref_primary_10_22328_2077_9828_2021_13_3_30_39 crossref_primary_10_3390_biology11010061 crossref_primary_10_1016_j_biopha_2020_110914 crossref_primary_10_1016_j_prp_2024_155373 crossref_primary_10_18006_2022_10_5__960_977 crossref_primary_10_1002_cbin_11997 crossref_primary_10_3389_fimmu_2020_570993 crossref_primary_10_3390_healthcare11111584 crossref_primary_10_3390_ph16091196 crossref_primary_10_1016_j_jviromet_2022_114475 crossref_primary_10_1128_mBio_01599_21 crossref_primary_10_2139_ssrn_3739821 crossref_primary_10_1002_rmv_2526 crossref_primary_10_3390_healthcare10122456 crossref_primary_10_22159_ijap_2022_v14s5_17 crossref_primary_10_3389_fcimb_2021_761521 crossref_primary_10_14336_AD_2021_0222 crossref_primary_10_1002_jmv_29097 crossref_primary_10_3389_fimmu_2021_622176 crossref_primary_10_1038_s41598_022_05097_y crossref_primary_10_1111_all_14472 crossref_primary_10_3390_ph13090236 crossref_primary_10_17343_sdutfd_971047 crossref_primary_10_2147_CCIDE_S315419 crossref_primary_10_56484_iamr_1197191 crossref_primary_10_1177_03000605241233450 crossref_primary_10_37871_jbres1372 crossref_primary_10_1016_j_jsams_2021_07_003 crossref_primary_10_1016_j_diabres_2023_110896 crossref_primary_10_3389_fimmu_2024_1374828 crossref_primary_10_3389_fimmu_2021_680134 crossref_primary_10_3390_metabo11010044 crossref_primary_10_53394_akd_1037367 crossref_primary_10_1038_s41423_023_00985_3 crossref_primary_10_1111_cea_13746 crossref_primary_10_3389_fimmu_2020_556335 crossref_primary_10_1016_j_ymthe_2024_03_029 crossref_primary_10_3390_pathogens12010109 crossref_primary_10_1007_s00109_022_02182_7 crossref_primary_10_1007_s00011_021_01473_y crossref_primary_10_1177_1759720X221130485 crossref_primary_10_1007_s12035_021_02464_0 crossref_primary_10_18499_1990_472X_2023_1_91_17_23 crossref_primary_10_1016_j_stem_2020_12_018 crossref_primary_10_1136_postgradmedj_2020_138791 crossref_primary_10_1371_journal_pone_0269864 crossref_primary_10_1007_s11010_023_04848_3 crossref_primary_10_3389_fimmu_2022_946730 crossref_primary_10_1016_j_thromres_2022_03_022 crossref_primary_10_35848_1347_4065_ac19d1 crossref_primary_10_1016_j_thromres_2023_01_016 crossref_primary_10_1038_s41467_023_37835_9 crossref_primary_10_3389_fimmu_2023_1127358 crossref_primary_10_2147_IJGM_S444318 crossref_primary_10_1016_j_arbr_2020_08_011 crossref_primary_10_1016_j_medcli_2022_03_013 crossref_primary_10_1080_07391102_2023_2167114 crossref_primary_10_1590_1806_9282_20200938 crossref_primary_10_3892_br_2024_1791 crossref_primary_10_1017_S0954422421000317 crossref_primary_10_1128_spectrum_04690_22 crossref_primary_10_1002_jmv_29673 crossref_primary_10_1016_j_jbspin_2021_105150 crossref_primary_10_3748_wjg_v27_i14_1406 crossref_primary_10_1016_j_biopha_2021_111272 crossref_primary_10_21055_0370_1069_2021_3_114_121 crossref_primary_10_17650_1726_9784_2021_22_1_71_75 crossref_primary_10_1016_j_snb_2021_130394 crossref_primary_10_1038_s41467_021_21503_x crossref_primary_10_1016_j_medcle_2022_03_020 crossref_primary_10_1186_s12985_024_02342_w crossref_primary_10_3390_ijms222010963 crossref_primary_10_1155_2021_6658270 crossref_primary_10_3389_fimmu_2021_720716 crossref_primary_10_3390_v13010040 crossref_primary_10_34108_eujhs_809210 crossref_primary_10_4103_lungindia_lungindia_583_20 crossref_primary_10_1016_j_anai_2020_06_018 crossref_primary_10_1152_ajplung_00332_2020 crossref_primary_10_3389_fphar_2021_708302 crossref_primary_10_1080_1040841X_2020_1822279 crossref_primary_10_3390_vaccines8030386 crossref_primary_10_1093_cid_ciaa1288 crossref_primary_10_1007_s10557_020_07073_y crossref_primary_10_1016_j_fertnstert_2020_12_033 crossref_primary_10_1186_s12979_020_00194_w crossref_primary_10_3390_ijms23010168 crossref_primary_10_1080_08820139_2020_1823407 crossref_primary_10_1186_s13054_020_03374_8 crossref_primary_10_1016_j_jaip_2020_09_039 crossref_primary_10_1186_s43141_022_00344_1 crossref_primary_10_1002_iub_2552 crossref_primary_10_1007_s12035_022_02932_1 crossref_primary_10_3390_microorganisms9122578 crossref_primary_10_1080_08998280_2020_1829261 crossref_primary_10_1097_MD_0000000000027400 crossref_primary_10_1177_21501327211030826 crossref_primary_10_2174_2772270816666220318103929 crossref_primary_10_3390_biomedicines11020452 crossref_primary_10_1515_almed_2021_0017 crossref_primary_10_3390_biomedicines9101342 crossref_primary_10_3390_vaccines9080848 crossref_primary_10_46392_kjge_2020_14_6_53 crossref_primary_10_1007_s40520_021_01942_8 crossref_primary_10_3389_fimmu_2023_1324084 crossref_primary_10_36604_1998_5029_2022_85_143_150 crossref_primary_10_1007_s40495_022_00301_z crossref_primary_10_1016_j_jaci_2023_05_008 crossref_primary_10_1002_jmv_28000 crossref_primary_10_1016_j_chest_2020_11_050 crossref_primary_10_1007_s40473_021_00235_8 crossref_primary_10_1080_03007995_2021_1914943 crossref_primary_10_1111_pbi_13970 crossref_primary_10_1590_1677_5449_200071 crossref_primary_10_1590_1677_5449_200072 crossref_primary_10_2174_26669587_v2_e2206200 crossref_primary_10_1111_all_14953 crossref_primary_10_1111_all_15800 crossref_primary_10_1134_S1019331622040177 crossref_primary_10_1128_Spectrum_00735_21 crossref_primary_10_1186_s12887_024_04821_z crossref_primary_10_1002_jmv_27166 crossref_primary_10_3390_medicina57121321 crossref_primary_10_3390_jcm10071337 crossref_primary_10_1016_j_intimp_2021_108137 crossref_primary_10_33808_clinexphealthsci_1016454 crossref_primary_10_1016_j_xjtc_2023_01_006 crossref_primary_10_2174_1389201022666210322124348 crossref_primary_10_1007_s11739_020_02569_9 crossref_primary_10_1002_mco2_154 crossref_primary_10_1089_ten_tec_2022_0160 crossref_primary_10_1007_s12471_020_01475_1 crossref_primary_10_1016_j_jss_2024_01_021 crossref_primary_10_1128_spectrum_00405_22 crossref_primary_10_5937_hraIsh2002078V crossref_primary_10_1111_all_14840 crossref_primary_10_3390_v16020292 crossref_primary_10_1016_j_heliyon_2023_e23583 crossref_primary_10_2139_ssrn_4197701 crossref_primary_10_1038_s41392_021_00679_0 crossref_primary_10_3389_fped_2021_645063 crossref_primary_10_1111_bjh_18062 crossref_primary_10_1136_bmjopen_2022_071072 crossref_primary_10_3390_ijms23116050 crossref_primary_10_7759_cureus_14020 crossref_primary_10_1038_s41598_021_00990_4 crossref_primary_10_1002_ptr_8105 crossref_primary_10_3389_fmed_2021_710010 crossref_primary_10_1111_all_14608 crossref_primary_10_1111_all_14607 crossref_primary_10_12998_wjcc_v8_i17_3621 crossref_primary_10_2147_IDR_S417062 crossref_primary_10_3390_jcm10040686 crossref_primary_10_4103_IJPM_IJPM_779_20 crossref_primary_10_3346_jkms_2020_35_e343 crossref_primary_10_31362_patd_900915 crossref_primary_10_3390_cells10123291 crossref_primary_10_3390_jpm13020334 crossref_primary_10_1007_s11356_021_16096_3 crossref_primary_10_2147_NDS_S294231 crossref_primary_10_3389_fimmu_2022_840137 crossref_primary_10_1016_j_acthis_2022_151908 crossref_primary_10_1177_1073858420941476 crossref_primary_10_4236_ojbiphy_2021_111001 crossref_primary_10_1111_all_14850 crossref_primary_10_1111_1756_185X_14624 crossref_primary_10_3390_ijms25073935 crossref_primary_10_3389_fphys_2021_624675 crossref_primary_10_1111_pai_13737 crossref_primary_10_1093_gerona_glab078 crossref_primary_10_1155_2021_8870425 crossref_primary_10_1038_s41598_021_86735_9 crossref_primary_10_3389_fimmu_2021_635985 crossref_primary_10_3390_vaccines10040614 crossref_primary_10_14218_JCTH_2020_00126 crossref_primary_10_3389_fnins_2021_694446 crossref_primary_10_3389_fnut_2022_825629 crossref_primary_10_1002_ptr_7008 crossref_primary_10_1007_s12291_020_00948_9 crossref_primary_10_1016_j_celrep_2022_111148 crossref_primary_10_1111_ped_15461 crossref_primary_10_25259_JRHM_10_2021 crossref_primary_10_1016_j_brainresbull_2022_06_014 crossref_primary_10_1097_INF_0000000000003669 crossref_primary_10_1111_dth_14204 crossref_primary_10_17816_brmma83090 crossref_primary_10_1007_s12035_020_02134_7 crossref_primary_10_1186_s12879_024_09464_0 crossref_primary_10_1371_journal_pone_0267423 crossref_primary_10_1111_all_14983 crossref_primary_10_1155_2022_1476233 crossref_primary_10_18632_aging_203307 crossref_primary_10_1111_all_14866 crossref_primary_10_1515_cclm_2020_1758 crossref_primary_10_1016_j_bbi_2020_07_016 crossref_primary_10_1183_23120541_00059_2021 crossref_primary_10_4103_psychiatry_IndianJPsychiatry_850_20 crossref_primary_10_18632_aging_202691 crossref_primary_10_1111_all_14746 crossref_primary_10_1016_j_intimp_2022_109615 crossref_primary_10_1093_cid_ciaa1250 crossref_primary_10_1038_s41392_021_00764_4 crossref_primary_10_3390_jcm12072568 crossref_primary_10_1016_j_tacc_2020_08_009 crossref_primary_10_1080_14737159_2022_2052047 crossref_primary_10_3389_fimmu_2023_1244556 crossref_primary_10_1097_EC9_0000000000000092 crossref_primary_10_1136_bmjopen_2020_043112 crossref_primary_10_3390_applmicrobiol2030045 crossref_primary_10_1016_j_chest_2020_10_054 crossref_primary_10_1016_j_snb_2023_135196 crossref_primary_10_2147_JIR_S307333 crossref_primary_10_3389_fphar_2021_614586 crossref_primary_10_3390_jcm13133987 crossref_primary_10_1007_s11906_022_01222_4 crossref_primary_10_1016_j_kint_2021_05_032 crossref_primary_10_1016_j_micpath_2022_105416 crossref_primary_10_1111_all_14991 crossref_primary_10_1093_infdis_jiae207 crossref_primary_10_3389_fmed_2022_802312 crossref_primary_10_1080_26895293_2021_1879280 crossref_primary_10_3390_ijerph18031093 crossref_primary_10_3390_covid4020014 crossref_primary_10_3233_HAB_210440 crossref_primary_10_3390_healthcare9091144 crossref_primary_10_3390_ijms241411508 crossref_primary_10_3390_jcm11175019 crossref_primary_10_29413_ABS_2022_7_5_2_9 crossref_primary_10_1186_s12872_020_01665_0 crossref_primary_10_1002_jgm_3435 crossref_primary_10_3389_fped_2021_661206 crossref_primary_10_1016_j_imbio_2023_152392 crossref_primary_10_2174_1574885515999201231204530 crossref_primary_10_1089_jir_2024_0018 crossref_primary_10_1007_s00705_023_05861_z crossref_primary_10_3390_diagnostics11050869 crossref_primary_10_18359_rmed_5798 crossref_primary_10_3389_fimmu_2022_864278 crossref_primary_10_1016_j_heliyon_2020_e05798 crossref_primary_10_3390_vaccines10122043 crossref_primary_10_1111_febs_15609 crossref_primary_10_1111_all_16028 crossref_primary_10_3390_diagnostics11081486 crossref_primary_10_1111_ddg_14195_g crossref_primary_10_1097_ACI_0000000000000700 crossref_primary_10_3390_ijms22158004 crossref_primary_10_1016_j_jiph_2022_10_006 crossref_primary_10_26442_00403660_2020_12_200522 crossref_primary_10_1038_s41421_021_00274_1 crossref_primary_10_1155_2021_6659410 crossref_primary_10_3390_v15051186 crossref_primary_10_1186_s12931_022_02190_8 crossref_primary_10_3390_molecules27206934 crossref_primary_10_1136_emermed_2020_210411 crossref_primary_10_3389_fphys_2020_616552 crossref_primary_10_1080_08923973_2021_1925906 crossref_primary_10_1016_j_jaut_2023_103118 crossref_primary_10_3389_fphar_2020_607075 crossref_primary_10_47855_jal9020_2022_3_2 crossref_primary_10_3389_fimmu_2021_642860 crossref_primary_10_1016_j_jped_2020_08_001 crossref_primary_10_1016_j_parint_2020_102241 crossref_primary_10_1089_acu_2020_1473 crossref_primary_10_3389_fpubh_2022_1032957 crossref_primary_10_1021_acsomega_2c04518 crossref_primary_10_3389_fphar_2021_734450 crossref_primary_10_3390_bioengineering8050054 crossref_primary_10_4168_aair_2023_15_6_705 crossref_primary_10_3390_microorganisms10030501 crossref_primary_10_1155_2022_4270096 crossref_primary_10_3390_v15051052 crossref_primary_10_1007_s12038_021_00145_7 crossref_primary_10_3390_ijms222112024 crossref_primary_10_3390_pathogens12070928 crossref_primary_10_3390_vaccines10020154 crossref_primary_10_18006_2022_10_3__487_493 crossref_primary_10_3389_fimmu_2021_809244 crossref_primary_10_1093_intimm_dxab107 crossref_primary_10_1080_14760584_2022_2016401 crossref_primary_10_15789_1563_0625_FOH_2452 crossref_primary_10_1016_j_diagmicrobio_2020_115128 crossref_primary_10_3390_life12071072 crossref_primary_10_1002_cti2_1224 crossref_primary_10_3389_fpubh_2021_559595 crossref_primary_10_3889_aph_2021_6006 crossref_primary_10_1016_j_idc_2022_01_003 crossref_primary_10_3390_vaccines12030229 crossref_primary_10_3390_biomedicines9111675 crossref_primary_10_1371_journal_pone_0287107 crossref_primary_10_1007_s00251_023_01295_8 crossref_primary_10_1016_j_rmcr_2020_101252 crossref_primary_10_3390_life11111152 crossref_primary_10_1016_j_prmcm_2022_100195 crossref_primary_10_17816_dv83044 crossref_primary_10_3390_ijms23052873 crossref_primary_10_3390_ph14080751 crossref_primary_10_1186_s12890_021_01422_9 crossref_primary_10_1111_imj_15728 crossref_primary_10_21931_RB_2020_05_03_21 crossref_primary_10_1186_s40798_022_00442_x crossref_primary_10_4254_wjh_v13_i12_1850 crossref_primary_10_1007_s40291_020_00486_3 crossref_primary_10_1186_s13020_021_00478_3 crossref_primary_10_1371_journal_pone_0255524 crossref_primary_10_2478_s11756_020_00614_8 crossref_primary_10_1371_journal_pone_0258913 crossref_primary_10_2147_IJGM_S381404 crossref_primary_10_3390_ijms24043591 crossref_primary_10_1186_s12879_021_06278_2 crossref_primary_10_1002_jmv_26232 crossref_primary_10_1097_ACI_0000000000000734 crossref_primary_10_1016_j_lfs_2023_121907 crossref_primary_10_1099_jgv_0_001692 crossref_primary_10_21682_2311_1267_2020_7_3_47_53 crossref_primary_10_36106_ijar_3713855 crossref_primary_10_7554_eLife_68874 crossref_primary_10_3390_pathogens11091050 crossref_primary_10_3389_fimmu_2024_1406291 crossref_primary_10_1021_acsnano_1c01845 crossref_primary_10_25259_AUJMSR_44_2022 crossref_primary_10_1038_s41598_024_52625_z crossref_primary_10_7883_yoken_JJID_2021_020 crossref_primary_10_1080_10641955_2021_1965621 crossref_primary_10_1177_11795514231189073 crossref_primary_10_1007_s00284_021_02396_x crossref_primary_10_3389_fimmu_2021_602130 crossref_primary_10_1016_j_talanta_2020_121898 crossref_primary_10_1016_j_trsl_2020_08_004 crossref_primary_10_2139_ssrn_3950210 crossref_primary_10_1177_14604582221120344 crossref_primary_10_1111_joim_13267 crossref_primary_10_1177_1535370220986785 crossref_primary_10_1007_s12015_020_10048_z crossref_primary_10_3390_ijerph18105086 crossref_primary_10_1111_imcb_12504 crossref_primary_10_3390_jpm12111770 crossref_primary_10_3390_jpm11030195 crossref_primary_10_1177_22799036221104173 crossref_primary_10_3390_jcm10214847 crossref_primary_10_1080_21645515_2022_2057161 crossref_primary_10_1016_j_jmsacl_2021_09_001 crossref_primary_10_3390_v14091916 crossref_primary_10_1016_j_advms_2022_11_001 crossref_primary_10_1017_S095026882200125X crossref_primary_10_3389_fimmu_2023_1111644 crossref_primary_10_1038_s41467_021_25191_5 crossref_primary_10_3390_ijms222111483 crossref_primary_10_1016_j_jfma_2021_06_009 crossref_primary_10_2147_JIR_S333887 crossref_primary_10_3389_fgene_2021_637362 crossref_primary_10_3390_ijms23031714 crossref_primary_10_1016_j_jcrc_2020_07_001 crossref_primary_10_3390_jcm11175081 crossref_primary_10_1002_advs_202001435 crossref_primary_10_1016_j_heliyon_2021_e06836 crossref_primary_10_1007_s11060_022_04205_2 crossref_primary_10_1017_S0950268820002150 crossref_primary_10_1021_acs_analchem_3c01758 crossref_primary_10_3389_fimmu_2020_610688 crossref_primary_10_1097_ID9_0000000000000048 crossref_primary_10_1080_07853890_2022_2095667 crossref_primary_10_15360_1813_9779_2020_6_4_18 crossref_primary_10_1038_s41419_022_04589_z crossref_primary_10_4049_jimmunol_2001438 crossref_primary_10_14336_AD_2020_1124 crossref_primary_10_3390_ijerph20032275 crossref_primary_10_1177_1074248421995356 crossref_primary_10_3390_vaccines9020102 crossref_primary_10_18034_ajase_v10i1_17 crossref_primary_10_1134_S0022093021040177 crossref_primary_10_15789_2220_7619_OFC_1917 crossref_primary_10_3390_ijms232314592 crossref_primary_10_1080_03091902_2021_1921067 crossref_primary_10_3390_microorganisms11010223 crossref_primary_10_1016_j_bjid_2021_101606 crossref_primary_10_1016_j_heliyon_2023_e19345 crossref_primary_10_1158_2159_8290_CD_21_1368 crossref_primary_10_2217_fmb_2020_0199 crossref_primary_10_1016_j_biopha_2023_115493 crossref_primary_10_1007_s10096_023_04744_0 crossref_primary_10_1080_15321819_2021_1895214 crossref_primary_10_1016_j_envint_2021_106695 crossref_primary_10_5492_wjccm_v10_i5_244 crossref_primary_10_1007_s10555_022_10019_5 crossref_primary_10_1134_S0022093022010070 crossref_primary_10_2174_1871526521666210720124950 crossref_primary_10_4103_jfmpc_jfmpc_617_21 crossref_primary_10_1016_j_ijregi_2023_03_011 crossref_primary_10_1089_vim_2020_0174 crossref_primary_10_3389_fimmu_2021_700705 crossref_primary_10_1007_s10557_020_07120_8 crossref_primary_10_1177_20499361211032453 crossref_primary_10_1016_j_addr_2020_12_011 crossref_primary_10_3390_vaccines11030659 crossref_primary_10_1172_jci_insight_160332 crossref_primary_10_51847_eilLCorjfQ crossref_primary_10_3389_fimmu_2022_856883 crossref_primary_10_1038_s41408_021_00594_1 crossref_primary_10_1111_ddg_14195 crossref_primary_10_1016_j_prp_2022_154131 crossref_primary_10_1002_rmv_2194 crossref_primary_10_1089_vim_2020_0166 crossref_primary_10_1021_acssensors_1c01527 crossref_primary_10_1080_23744235_2021_1916071 crossref_primary_10_3947_ic_2020_52_4_461 crossref_primary_10_18093_0869_0189_2021_31_6_792_798 crossref_primary_10_1186_s12985_023_02165_1 crossref_primary_10_2217_fvl_2021_0048 crossref_primary_10_3390_ijerph182011001 crossref_primary_10_1016_j_jiph_2020_12_019 crossref_primary_10_1002_jum_15563 crossref_primary_10_1007_s10654_020_00709_1 crossref_primary_10_1111_all_15333 crossref_primary_10_1007_s13167_023_00317_5 crossref_primary_10_1111_all_15218 crossref_primary_10_1016_j_biologicals_2021_11_002 crossref_primary_10_2217_bmm_2022_0265 crossref_primary_10_1038_s41598_021_84565_3 crossref_primary_10_2147_IDR_S448713 crossref_primary_10_3389_fimmu_2021_797117 crossref_primary_10_3389_fphar_2021_656103 crossref_primary_10_3390_v15061262 crossref_primary_10_1093_jac_dkaa564 crossref_primary_10_3934_Allergy_2020006 crossref_primary_10_1007_s12291_021_00972_3 crossref_primary_10_1016_j_intimp_2020_107330 crossref_primary_10_1016_j_arcmed_2021_05_003 crossref_primary_10_1038_s41422_021_00519_4 crossref_primary_10_3389_fimmu_2021_697622 crossref_primary_10_3390_biologics3020008 crossref_primary_10_3389_fimmu_2021_788769 crossref_primary_10_1016_j_jep_2023_117381 crossref_primary_10_1111_all_14498 crossref_primary_10_1016_j_jmgm_2021_107997 crossref_primary_10_1097_RCT_0000000000001425 crossref_primary_10_7717_peerj_12595 crossref_primary_10_23736_S2724_606X_21_04979_4 crossref_primary_10_1186_s43094_024_00636_y crossref_primary_10_1016_j_jsps_2023_02_011 crossref_primary_10_3390_cells11050847 crossref_primary_10_51758_AGJSR_S2_2021_0019 crossref_primary_10_1021_acsomega_1c04012 crossref_primary_10_1016_j_biochi_2021_02_012 crossref_primary_10_1186_s13052_021_01198_y crossref_primary_10_3390_vaccines9060596 crossref_primary_10_1016_j_celrep_2021_109391 crossref_primary_10_1080_07391102_2023_2245039 crossref_primary_10_1038_s41392_021_00736_8 crossref_primary_10_1111_all_15593 crossref_primary_10_3389_fphar_2021_622554 crossref_primary_10_1002_eji_202149319 crossref_primary_10_1093_infdis_jiaa713 crossref_primary_10_2174_1573397118666220211155716 crossref_primary_10_1089_ped_2020_1214 crossref_primary_10_3389_fneur_2021_657037 crossref_primary_10_1016_j_ijantimicag_2021_106334 crossref_primary_10_1111_all_15239 crossref_primary_10_1016_j_isci_2023_106935 crossref_primary_10_1080_21505594_2022_2090071 crossref_primary_10_1186_s12959_021_00311_9 crossref_primary_10_1002_advs_202305554 crossref_primary_10_1098_rsos_211606 crossref_primary_10_1002_jmv_26742 crossref_primary_10_1016_j_redox_2021_101976 crossref_primary_10_1007_s00431_021_04124_w crossref_primary_10_1007_s10555_021_10017_z crossref_primary_10_2217_fmb_2022_0057 crossref_primary_10_1155_2024_7484645 crossref_primary_10_1099_acmi_0_000267 crossref_primary_10_1007_s40279_022_01751_7 crossref_primary_10_1016_j_heliyon_2023_e14015 crossref_primary_10_1111_sji_13108 crossref_primary_10_15789_2220_7619_TRO_2058 crossref_primary_10_1080_19490976_2022_2073131 crossref_primary_10_3389_fmicb_2023_1122868 crossref_primary_10_2139_ssrn_3729674 crossref_primary_10_1159_000513214 crossref_primary_10_3389_fphar_2020_615972 crossref_primary_10_1111_all_15247 crossref_primary_10_3390_ijms24032852 crossref_primary_10_25122_jml_2021_0239 crossref_primary_10_3390_vaccines8040649 crossref_primary_10_17343_sdutfd_906925 crossref_primary_10_1002_jmv_26504 crossref_primary_10_7705_biomedica_5976 crossref_primary_10_1007_s00134_020_06223_y crossref_primary_10_1183_16000617_0197_2022 crossref_primary_10_3390_jcm12103415 crossref_primary_10_2174_1389450121666201020154033 crossref_primary_10_3390_v13061171 crossref_primary_10_3390_medsci10020029 crossref_primary_10_23736_S2784_8477_21_01914_3 crossref_primary_10_15789_1563_0625_COI_2852 crossref_primary_10_37349_ei_2022_00049 crossref_primary_10_1002_jum_15417 crossref_primary_10_3389_fbioe_2023_1202126 crossref_primary_10_51758_AGJSR_02_2021_0019 crossref_primary_10_1016_j_jiph_2022_01_007 crossref_primary_10_1038_s41598_021_95045_z crossref_primary_10_1183_23120541_00741_2020 crossref_primary_10_1080_25785826_2020_1870305 crossref_primary_10_7717_peerj_14227 crossref_primary_10_1016_j_ijcha_2021_100950 crossref_primary_10_3389_fimmu_2022_891456 crossref_primary_10_1111_all_15373 crossref_primary_10_22209_IC_v61n3a07 crossref_primary_10_33713_egetbd_1167278 crossref_primary_10_1111_all_15258 crossref_primary_10_1111_trf_17843 crossref_primary_10_1111_all_15136 crossref_primary_10_1016_j_cmpb_2021_106412 crossref_primary_10_3390_jpm12050849 crossref_primary_10_1016_j_biopha_2022_113499 crossref_primary_10_1016_j_eclinm_2021_101112 crossref_primary_10_1007_s10787_021_00908_6 crossref_primary_10_3390_v15101976 crossref_primary_10_3390_cells10112949 crossref_primary_10_1016_j_jaci_2020_10_040 crossref_primary_10_3390_biomedicines10112770 crossref_primary_10_1515_almed_2020_0069 crossref_primary_10_1016_j_mjafi_2021_02_008 crossref_primary_10_1186_s12951_023_01981_5 crossref_primary_10_3390_ijms232314766 crossref_primary_10_3389_fneur_2020_01031 crossref_primary_10_1016_j_intimp_2022_109277 crossref_primary_10_4103_lungindia_lungindia_426_23 crossref_primary_10_16899_jcm_1119530 crossref_primary_10_3390_medicina57111189 crossref_primary_10_38137_vetfarmatoksbulten_768811 crossref_primary_10_2478_rrlm_2021_0026 crossref_primary_10_3390_biomedicines10071464 crossref_primary_10_1016_j_xcrm_2022_100680 crossref_primary_10_1016_j_opresp_2022_100162 crossref_primary_10_3389_fimmu_2021_626235 crossref_primary_10_1016_j_virusres_2024_199339 crossref_primary_10_3390_ijms24054523 crossref_primary_10_2478_rrlm_2021_0022 crossref_primary_10_26416_Med_141_3_2021_4980 crossref_primary_10_2147_IJGM_S389300 crossref_primary_10_22159_ijap_2023v15i6_48889 crossref_primary_10_1183_23120541_00457_2020 crossref_primary_10_1111_all_15148 crossref_primary_10_2147_IDR_S307238 crossref_primary_10_12688_f1000research_74023_1 crossref_primary_10_12688_f1000research_74023_2 crossref_primary_10_1590_1678_9199_jvatitd_2020_0157 crossref_primary_10_1177_08850666211053548 crossref_primary_10_3389_fped_2022_790273 crossref_primary_10_1097_QAI_0000000000002837 crossref_primary_10_3389_fnano_2021_644023 crossref_primary_10_3201_eid2704_204337 crossref_primary_10_1016_j_micinf_2023_105188 crossref_primary_10_1016_j_waojou_2021_100514 crossref_primary_10_1016_j_heliyon_2023_e17478 crossref_primary_10_3389_fmed_2021_664179 crossref_primary_10_1002_cyto_a_24172 crossref_primary_10_1111_sji_13039 crossref_primary_10_3389_fmicb_2023_1162470 crossref_primary_10_3390_pathogens9110917 crossref_primary_10_1111_sji_13275 crossref_primary_10_2478_jtim_2020_0019 crossref_primary_10_3390_jcm9113630 crossref_primary_10_1016_j_bbih_2021_100297 crossref_primary_10_1111_bjh_17503 crossref_primary_10_3389_fcell_2022_914891 crossref_primary_10_1016_j_heliyon_2022_e09302 crossref_primary_10_1016_j_jaip_2021_06_045 crossref_primary_10_1007_s42452_023_05419_3 crossref_primary_10_1371_journal_pone_0283589 crossref_primary_10_1016_j_isci_2020_101631 crossref_primary_10_1016_j_vacune_2022_06_002 crossref_primary_10_3390_vaccines11020480 crossref_primary_10_1111_ijcp_14767 crossref_primary_10_1186_s12974_022_02514_x crossref_primary_10_1007_s10238_023_01293_w crossref_primary_10_3390_ijms22063059 crossref_primary_10_1186_s13619_022_00149_0 crossref_primary_10_3390_cancers13112676 crossref_primary_10_1016_j_wneu_2020_06_115 crossref_primary_10_3390_ijms232113103 crossref_primary_10_3390_vaccines9040316 crossref_primary_10_4103_ijem_IJEM_440_20 crossref_primary_10_3389_fphar_2021_747450 crossref_primary_10_1186_s13027_022_00459_7 crossref_primary_10_1016_j_intimp_2023_110578 crossref_primary_10_1002_iid3_526 crossref_primary_10_3390_biology12070949 crossref_primary_10_3390_biomedicines10112850 crossref_primary_10_36691_RJA1382 crossref_primary_10_1007_s11739_021_02659_2 crossref_primary_10_2174_1872208316666220106110014 crossref_primary_10_37349_ei_2021_00011 crossref_primary_10_1038_s41392_022_01249_8 crossref_primary_10_1002_iid3_402 crossref_primary_10_11569_wcjd_v31_i11_431 crossref_primary_10_1093_cid_ciaa1703 |
Cites_doi | 10.1056/NEJMoa2006100 10.1016/j.cca.2020.03.004 10.1056/NEJMoa2002032 10.1080/08830185.2020.1756284 10.1016/S2213-2600(20)30127-2 10.1111/all.14289 10.1111/all.13811 10.1016/j.hjc.2020.03.002 10.4269/ajtmh.15-0920 10.1001/jama.2020.4914 10.1055/s-0040-1709498 10.1038/s41392-020-0148-4 10.1111/imr.12555 10.1001/jama.2020.0757 10.1016/S0264-410X(96)00128-4 10.1002/jmv.25783 10.1038/s41423-020-0401-3 10.1038/nri3859 10.1002/jmv.20255 10.1016/j.micinf.2012.10.008 10.1016/j.ijid.2020.03.053 10.1038/s41423-020-0498-4 10.1152/physrev.00013.2020 10.3390/pathogens8030147 10.1016/j.cell.2020.02.052 10.1080/22221751.2020.1736644 10.1001/jamainternmed.2020.0994 10.1093/cid/ciaa414 10.1111/all.14157 10.1001/jama.2020.4783 10.1002/ppul.24718 10.1093/ajcp/aqaa062 10.4049/jimmunol.172.7.4123 10.1001/jama.2020.2565 10.1002/art.40071 10.1007/s00134-020-05991-x 10.5114/ait.2020.93756 10.1038/s41586-020-2012-7 10.1038/s41423-020-0402-2 10.1038/s41564-020-0695-z 10.3390/v12030254 10.3390/ijms151017411 10.1016/j.jcv.2019.08.009 10.1016/j.jinf.2020.02.029 10.4269/ajtmh.16-0387 10.1016/j.eururo.2020.03.030 10.1038/s41467-020-15562-9 10.1128/mBio.00845-17 10.1001/jamaophthalmol.2020.1291 10.1292/jvms.18-0582 10.1001/jama.2020.1585 10.3389/fimmu.2018.00678 10.1016/0264-410X(90)90250-P 10.1093/infdis/jiv321 10.1099/vir.0.81579-0 10.1016/j.abb.2019.07.013 10.1111/liv.14455 10.1093/cid/ciaa538 10.7326/M20-0533 10.1002/eji.1830140414 10.1111/all.14345 10.1016/j.jtho.2020.02.010 10.4049/jimmunol.173.3.1978 10.1016/S1473-3099(20)30196-1 10.1093/cid/ciaa248 10.1164/rccm.202003-0543OC 10.1093/infdis/jiaa150 10.1099/0022-1317-70-12-3291 10.1111/all.14360 10.1093/cid/ciaa310 10.1002/jmv.25770 10.1038/s41586-020-2286-9 10.1126/science.abb7015 10.1007/s12015-020-09976-7 10.1111/all.14238 10.1172/JCI138003 10.1001/jama.2020.4326 10.1016/j.chom.2020.03.023 10.1016/j.ajpath.2015.10.024 10.1371/journal.pone.0220196 10.1136/bmj.m1091 10.1016/S2213-2600(20)30079-5 10.1016/j.chom.2020.03.002 10.1016/j.jaci.2020.04.021 10.1074/jbc.M109.008227 10.1111/bcp.12165 10.1515/cclm-2020-0188 10.1007/s12519-020-00354-4 10.1016/S0140-6736(20)30183-5 10.1056/NEJMoa1211721 10.1002/path.1440 10.3389/fimmu.2018.03022 10.1038/s41591-020-0897-1 10.3201/eid2607.200841 10.1097/CM9.0000000000000824 10.1016/j.jinf.2016.08.005 10.1080/22221751.2020.1747363 10.1172/JCI137244 10.1111/all.14126 10.1016/j.cell.2013.05.052 10.1016/S0140-6736(20)30566-3 10.1016/j.jaci.2009.02.030 10.1038/s41575-020-0295-7 10.1073/pnas.1217580110 10.1126/science.abb4489 10.1038/cmi.2015.74 10.1016/S0140-6736(03)13412-5 10.1016/j.virol.2006.11.027 10.1016/S2213-2600(20)30076-X 10.1007/s00281-017-0629-x 10.1111/all.14257 10.1002/jmv.25767 10.1152/ajplung.00155.2015 10.1016/j.kint.2020.03.005 10.1111/all.14344 10.1016/j.jinf.2020.04.019 10.1016/S1473-3099(20)30243-7 10.1038/s41577-020-0311-8 10.1111/aas.12034 10.1016/j.vaccine.2016.02.063 10.1073/pnas.2004999117 10.1089/vim.2018.0150 10.1136/jclinpath-2020-206522 10.1016/S0140-6736(20)30211-7 10.1016/j.micinf.2005.06.007 10.1007/s00281-017-0639-8 10.1001/jama.2017.21907 10.1056/NEJMoa2001017 10.1007/s11427-020-1643-8 10.1080/22221751.2020.1746199 10.1186/s13054-020-2818-6 10.3201/eid1005.030640 10.1002/jmv.25818 |
ContentType | Journal Article |
Copyright | 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
Copyright_xml | – notice: 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. – notice: Copyright © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 K9. 7X8 5PM |
DOI | 10.1111/all.14364 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | AZKUR et al |
EISSN | 1398-9995 |
EndPage | 1581 |
ExternalDocumentID | 10_1111_all_14364 32396996 ALL14364 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8F7 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB AOETA ATUGU AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D P6G PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI TR2 UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 Y6R ZGI ZXP ZZTAW ~IA ~KM ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c5094-8a7387e461043697a241b5c6bcc9e246e9ee5e877c8149ea58c1fbcf39f6f3c53 |
IEDL.DBID | DR2 |
ISSN | 0105-4538 |
IngestDate | Tue Sep 17 21:26:30 EDT 2024 Fri Aug 16 22:06:23 EDT 2024 Thu Oct 10 16:02:22 EDT 2024 Fri Aug 23 01:12:41 EDT 2024 Sat Nov 02 12:19:17 EDT 2024 Sat Aug 24 01:06:43 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | COVID-19 immunologic tests cytokine storm immunopathology immune response infections pandemic virus |
Language | English |
License | 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5094-8a7387e461043697a241b5c6bcc9e246e9ee5e877c8149ea58c1fbcf39f6f3c53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Azkur and Akdis are the first co‐authors. |
ORCID | 0000-0001-8020-019X 0000-0003-0554-9943 0000-0003-1251-7608 0000-0002-2146-2955 0000-0002-4396-9087 0000-0002-5597-8917 0000-0001-9710-6685 0000-0003-4705-3583 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7272948 |
PMID | 32396996 |
PQID | 2422434750 |
PQPubID | 34098 |
PageCount | 18 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7272948 proquest_miscellaneous_2402425542 proquest_journals_2422434750 crossref_primary_10_1111_all_14364 pubmed_primary_32396996 wiley_primary_10_1111_all_14364_ALL14364 |
PublicationCentury | 2000 |
PublicationDate | July 2020 2020-07-00 20200701 |
PublicationDateYYYYMMDD | 2020-07-01 |
PublicationDate_xml | – month: 07 year: 2020 text: July 2020 |
PublicationDecade | 2020 |
PublicationPlace | Denmark |
PublicationPlace_xml | – name: Denmark – name: Zurich – name: Hoboken |
PublicationTitle | Allergy (Copenhagen) |
PublicationTitleAlternate | Allergy |
PublicationYear | 2020 |
Publisher | Blackwell Publishing Ltd John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: John Wiley and Sons Inc |
References | 2017; 8 2020; 63 2019; 14 2020; 17 2020; 368 2020; 59 2016; 73 2020; 12 2020; 323 2020; 11 2020; 55 2012; 367 2009; 119 2013; 5 2017; 278 2016; 186 2016; 34 2020; 8 2018; 9 2020; 5 2013; 15 1984; 14 2020; 130 2020; 52 2017; 39 2013; 57 2015; 212 2004; 173 1989; 70 2004; 172 2020; 9 2014; 15 2016; 310 2020; 138 2020; 49 2009; 123 2005; 75 2020; 579 2019; 119 2020; 46 2009; 284 2013; 110 2013; 154 2003; 200 2019; 671 2003; 361 2019; 8 2015; 2 2015; 15 2015; 4 2020; 382 2019; 74 2017; 69 2019; 32 2020; 181 2007; 361 2020; 80 2008; 14 2006; 8 2020; 38 2016; 95 2016; 94 2020; 100 2020; 34 2020; 221 1996; 14 2020; 505 2016; 13 2004; 10 2019; 81 2020; 75 2013; 76 2020; 153 2006; 87 2020; 73 2020 2020; 395 2020; 27 2020; 117 2020; 26 2020; 24 2018; 319 1990; 8 e_1_2_16_23_1 e_1_2_16_46_1 e_1_2_16_27_1 e_1_2_16_69_1 e_1_2_16_117_1 e_1_2_16_42_1 e_1_2_16_88_1 e_1_2_16_65_1 e_1_2_16_113_1 e_1_2_16_136_1 e_1_2_16_120_1 e_1_2_16_80_1 e_1_2_16_101_1 Li YX (e_1_2_16_64_1) 2020; 59 e_1_2_16_15_1 e_1_2_16_38_1 e_1_2_16_19_1 e_1_2_16_34_1 e_1_2_16_57_1 e_1_2_16_30_1 e_1_2_16_53_1 e_1_2_16_76_1 e_1_2_16_99_1 e_1_2_16_105_1 e_1_2_16_128_1 e_1_2_16_11_1 e_1_2_16_109_1 e_1_2_16_124_1 e_1_2_16_95_1 e_1_2_16_72_1 e_1_2_16_91_1 e_1_2_16_131_1 Wang R (e_1_2_16_110_1) 2015; 4 e_1_2_16_9_1 e_1_2_16_5_1 e_1_2_16_26_1 e_1_2_16_49_1 e_1_2_16_45_1 e_1_2_16_68_1 e_1_2_16_41_1 e_1_2_16_87_1 Gonzales JN (e_1_2_16_122_1) 2015; 2 e_1_2_16_118_1 e_1_2_16_22_1 e_1_2_16_60_1 e_1_2_16_83_1 e_1_2_16_114_1 e_1_2_16_137_1 e_1_2_16_121_1 e_1_2_16_144_1 e_1_2_16_140_1 e_1_2_16_14_1 To KK (e_1_2_16_3_1) 2013; 5 e_1_2_16_18_1 e_1_2_16_56_1 e_1_2_16_37_1 e_1_2_16_79_1 e_1_2_16_98_1 e_1_2_16_52_1 e_1_2_16_129_1 e_1_2_16_33_1 e_1_2_16_75_1 e_1_2_16_102_1 e_1_2_16_71_1 e_1_2_16_94_1 e_1_2_16_10_1 e_1_2_16_125_1 e_1_2_16_106_1 e_1_2_16_8_1 e_1_2_16_90_1 e_1_2_16_132_1 Goh KJ (e_1_2_16_143_1) 2020; 49 Lanteri MC (e_1_2_16_61_1) 2009; 119 Zheng BJ (e_1_2_16_84_1) 2008; 14 e_1_2_16_4_1 e_1_2_16_25_1 e_1_2_16_29_1 e_1_2_16_67_1 e_1_2_16_48_1 e_1_2_16_63_1 e_1_2_16_119_1 e_1_2_16_44_1 e_1_2_16_86_1 e_1_2_16_21_1 e_1_2_16_115_1 e_1_2_16_138_1 e_1_2_16_40_1 e_1_2_16_82_1 e_1_2_16_145_1 e_1_2_16_141_1 e_1_2_16_13_1 Prompetchara E (e_1_2_16_112_1) 2020; 38 e_1_2_16_17_1 e_1_2_16_36_1 e_1_2_16_59_1 e_1_2_16_78_1 e_1_2_16_32_1 e_1_2_16_55_1 e_1_2_16_74_1 e_1_2_16_103_1 e_1_2_16_97_1 e_1_2_16_70_1 e_1_2_16_51_1 e_1_2_16_107_1 e_1_2_16_126_1 e_1_2_16_93_1 e_1_2_16_7_1 e_1_2_16_133_1 e_1_2_16_24_1 Conti P (e_1_2_16_28_1) 2020; 34 e_1_2_16_47_1 e_1_2_16_89_1 e_1_2_16_139_1 e_1_2_16_2_1 e_1_2_16_43_1 e_1_2_16_66_1 e_1_2_16_85_1 e_1_2_16_135_1 e_1_2_16_20_1 e_1_2_16_62_1 e_1_2_16_81_1 e_1_2_16_116_1 e_1_2_16_123_1 e_1_2_16_100_1 e_1_2_16_39_1 e_1_2_16_12_1 e_1_2_16_35_1 e_1_2_16_16_1 e_1_2_16_58_1 e_1_2_16_31_1 e_1_2_16_77_1 e_1_2_16_104_1 e_1_2_16_96_1 e_1_2_16_54_1 e_1_2_16_73_1 e_1_2_16_108_1 e_1_2_16_146_1 e_1_2_16_92_1 Zheng F (e_1_2_16_142_1) 2020; 24 e_1_2_16_50_1 e_1_2_16_127_1 e_1_2_16_111_1 e_1_2_16_134_1 e_1_2_16_6_1 e_1_2_16_130_1 |
References_xml | – volume: 81 start-page: 204 issue: 2 year: 2019 end-page: 212 article-title: Schmallenberg virus induces apoptosis in Vero cell line via extrinsic and intrinsic pathways in a time and dose dependent manner publication-title: J Vet Med Sci – volume: 100 start-page: 1065 issue: 3 year: 2020 end-page: 1075 article-title: Elevated plasmin(ogen) as a common risk factor for COVID‐19 susceptibility publication-title: Physiol Rev – year: 2020 article-title: Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center's observational study publication-title: World J Pediatr – volume: 119 start-page: 44 year: 2019 end-page: 52 article-title: Influenza virus‐specific CD4+ and CD8+ T cell‐mediated immunity induced by infection and vaccination publication-title: J Clin Virol – volume: 10 start-page: 818 issue: 5 year: 2004 end-page: 824 article-title: Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients publication-title: Emerg Infect Dis – volume: 75 start-page: 1815 year: 2020 end-page: 1819 article-title: Is global BCG vaccination‐induced trained immunity relevant to the progression of the SARS.CoV‐2 pandemic? publication-title: Allergy – volume: 75 start-page: 1205 issue: 5 year: 2020 end-page: 1216 article-title: CARsomes inhibit airway allergic inflammation in mice by inducing antigen‐specific Th2 cell apoptosis publication-title: Allergy – volume: 69 start-page: 1135 issue: 6 year: 2017 end-page: 1143 article-title: Review: cytokine storm syndrome: looking toward the precision medicine Era publication-title: Arthritis Rheumatol – year: 2020 article-title: Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID‐19) in Wuhan, China: a retrospective study publication-title: Chin Med J (Engl) – volume: 38 start-page: 1 issue: 1 year: 2020 end-page: 9 article-title: Immune responses in COVID‐19 and potential vaccines: Lessons learned from SARS and MERS epidemic publication-title: Asian Pac J Allergy Immunol – volume: 26 issue: 7 year: 2020 article-title: Severe acute respiratory syndrome Coronavirus 2−specific antibody responses in Coronavirus disease 2019 patients publication-title: Emerg Infect Dis – year: 2020 article-title: Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China publication-title: JAMA Intern Med – volume: 181 start-page: 271 issue: 2 year: 2020 end-page: 280 article-title: SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor publication-title: Cell – volume: 9 start-page: 3022 year: 2018 article-title: Fine tuning the cytokine storm by IFN and IL‐10 following neurotropic coronavirus encephalomyelitis publication-title: Front Immunol – year: 2020 article-title: Management of critically ill adults with COVID‐19 publication-title: JAMA – volume: 319 start-page: 698 issue: 7 year: 2018 end-page: 710 article-title: Acute respiratory distress syndrome: advances in diagnosis and treatment publication-title: JAMA – year: 2020 article-title: Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS‐CoV‐ 2: an observational cohort study publication-title: Lancet Infect Dis – year: 2020 article-title: Clinical characteristics of Coronavirus disease 2019 in China publication-title: N Engl J Med – year: 2020 article-title: Dynamics of anti‐SARS‐Cov‐2 IgM and IgG antibodies among COVID‐19 patients publication-title: J Infect – volume: 4 issue: 5 year: 2015 article-title: The role of C5a in acute lung injury induced by highly pathogenic viral infections publication-title: Emerg Microbes Infect – volume: 17 start-page: 541 issue: 5 year: 2020 end-page: 543 article-title: Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID‐19 patients publication-title: Cell Mol Immunol – year: 2020 article-title: Liver impairment in COVID‐19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China publication-title: Liver Int – volume: 671 start-page: 196 year: 2019 end-page: 202 article-title: Acute phase protein response to viral infection and vaccination publication-title: Arch Biochem Biophys – volume: 75 start-page: 185 issue: 2 year: 2005 end-page: 194 article-title: An interferon‐gamma‐related cytokine storm in SARS patients publication-title: J Med Virol – volume: 212 start-page: 2011 issue: 12 year: 2015 end-page: 2020 article-title: High anti‐dengue virus activity of the OAS gene family is associated with increased severity of dengue publication-title: J Infect Dis – volume: 14 start-page: 39 issue: Suppl 4 year: 2008 end-page: 43 article-title: Studies of SARS virus vaccines publication-title: Hong Kong Med J – volume: 73 start-page: 239 issue: 5 year: 2020 end-page: 242 article-title: Autopsy in suspected COVID‐19 cases publication-title: J Clin Pathol – year: 2020 article-title: Antibody responses to SARS‐CoV‐2 in patients with COVID‐19 publication-title: Nat Med – volume: 80 start-page: e23 issue: 5 year: 2020 end-page: e24 article-title: Lymphopenic community acquired pneumonia as signature of severe COVID‐19 infection publication-title: J Infect – year: 2020 article-title: Clinical and immunologic features in severe and moderate Coronavirus Disease 2019 publication-title: J Clin Invest – volume: 323 start-page: 707 issue: 8 year: 2020 article-title: Coronavirus infections‐more than just the common cold publication-title: JAMA – volume: 8 start-page: 420 issue: 4 year: 2020 end-page: 422 article-title: Pathological findings of COVID‐19 associated with acute respiratory distress syndrome publication-title: Lancet Respir Med – year: 2020 article-title: Prediction for progression risk in patients with COVID‐19 pneumonia: the CALL score publication-title: Clin Infect Dis – year: 2020 article-title: Prominent changes in blood coagulation of patients with SARS‐CoV‐2 infection publication-title: Clin Chem Lab Med – year: 2020 article-title: Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 publication-title: J Med Virol – volume: 221 start-page: 1762 issue: 11 year: 2020 end-page: 1769 article-title: Characteristics of peripheral lymphocyte subset alteration in COVID‐19 pneumonia publication-title: J Infect Dis – year: 2020 article-title: Histopathologic Changes and SARS‐CoV‐2 Immunostaining in the Lung of a Patient With COVID‐19 publication-title: Ann Intern Med – volume: 8 start-page: 479 issue: 5 year: 1990 end-page: 485 article-title: Functional role of respiratory tract haemagglutinin‐specific IgA antibodies in protection against influenza publication-title: Vaccine – year: 2020 article-title: Dysregulation of immune response in patients with COVID‐19 in Wuhan, China publication-title: Clin Infect Dis – year: 2020 article-title: Stability of regulatory T cells in T helper 2‐biased allergic airway diseases publication-title: Allergy – volume: 284 start-page: 16202 issue: 24 year: 2009 end-page: 16209 article-title: Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex publication-title: J Biol Chem – volume: 8 start-page: 475 issue: 5 year: 2020 end-page: 481 article-title: Clinical course and outcomes of critically ill patients with SARS‐CoV‐2 pneumonia in Wuhan, China: a single‐centered, retrospective, observational study publication-title: Lancet Respir Med – year: 2020 article-title: CD147 as a target for COVID‐19 treatment: suggested effects of azithromycin and stem cell engagement publication-title: Stem Cell Rev Rep – volume: 9 start-page: 761 issue: 1 year: 2020 end-page: 770 article-title: Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID‐19 patients publication-title: Emerg Microbes Infect – volume: 8 start-page: 433 issue: 5 year: 2020 end-page: 434 article-title: Treatment for severe acute respiratory distress syndrome from COVID‐19 publication-title: Lancet Respir Med – volume: 32 start-page: 198 issue: 5 year: 2019 end-page: 207 article-title: Eosinophils and respiratory viruses publication-title: Viral Immunol – volume: 75 start-page: 1730 year: 2020 end-page: 1741 article-title: Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China publication-title: Allergy – year: 2020 article-title: Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis publication-title: J Med Virol – volume: 75 start-page: 1822 year: 2020 end-page: 1824 article-title: SARS‐CoV‐2 immunogenecity at the crossroads publication-title: Allergy – volume: 73 start-page: 468 issue: 5 year: 2016 end-page: 475 article-title: Predictive factors for pneumonia development and progression to respiratory failure in MERS‐CoV infected patients publication-title: J Infect – year: 2020 article-title: The trinity of COVID‐19: immunity, inflammation and intervention publication-title: Nat Rev Immunol – year: 2020 article-title: Eosinophil responses during COVID‐19 infections and Coronavirus vaccination publication-title: J Allergy Clin Immunol – year: 2020 article-title: Pulmonary pathology of early‐phase 2019 novel Coronavirus (COVID‐19) pneumonia in two patients with lung cancer publication-title: J Thorac Oncol – volume: 8 issue: 5 year: 2017 article-title: Ebola virus binding to Tim‐1 on T lymphocytes induces a cytokine storm publication-title: MBio – volume: 27 start-page: 671 issue: 4 year: 2020 end-page: 680 article-title: A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS‐CoV‐2 publication-title: Cell Host Microbe – volume: 9 start-page: 558 issue: 1 year: 2020 end-page: 570 article-title: A tug‐of‐war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses publication-title: Emerg Microbes Infect – volume: 75 start-page: 1815 year: 2020 end-page: 1819 article-title: Is BCG vaccination effecting the spread and severity of COVID‐19 publication-title: Allergy – year: 2020 article-title: SARS‐CoV‐2 infects T lymphocytes through its spike protein‐mediated membrane fusion publication-title: Cell Mol Immunol – volume: 14 issue: 7 year: 2019 article-title: Superior immune responses induced by intranasal immunization with recombinant adenovirus‐based vaccine expressing full‐length Spike protein of Middle East respiratory syndrome coronavirus publication-title: PLoS One – volume: 57 start-page: 334 issue: 3 year: 2013 end-page: 341 article-title: An inhaled tumor necrosis factor‐alpha‐derived TIP peptide improves the pulmonary function in experimental lung injury publication-title: Acta Anaesthesiol Scand – year: 2020 article-title: Estimates of the severity of coronavirus disease 2019: a model‐based analysis publication-title: Lancet Infect Dis – volume: 154 start-page: 213 issue: 1 year: 2013 end-page: 227 article-title: Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation publication-title: Cell – year: 2020 article-title: Platelet‐to‐lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease‐19 publication-title: J Med Virol – volume: 17 start-page: 533 issue: 5 year: 2020 end-page: 535 article-title: Functional exhaustion of antiviral lymphocytes in COVID‐19 patients publication-title: Cell Mol Immunol – volume: 5 start-page: 536 issue: 4 year: 2020 end-page: 544 article-title: The species Severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2 publication-title: Nat Microbiol – volume: 55 start-page: 1169 issue: 5 year: 2020 end-page: 1174 article-title: Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults publication-title: Pediatr Pulmonol – volume: 34 start-page: 2008 issue: 17 year: 2016 end-page: 2014 article-title: Memory T cell responses targeting the SARS coronavirus persist up to 11 years post‐infection publication-title: Vaccine – volume: 173 start-page: 1978 issue: 3 year: 2004 end-page: 1986 article-title: Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract publication-title: J Immunol – volume: 39 start-page: 517 issue: 5 year: 2017 end-page: 528 article-title: Cytokine storm and sepsis disease pathogenesis publication-title: Semin Immunopathol – volume: 15 start-page: 88 issue: 2 year: 2013 end-page: 95 article-title: Extraordinary GU‐rich single‐strand RNA identified from SARS coronavirus contributes an excessive innate immune response publication-title: Microbes Infect – volume: 367 start-page: 1814 issue: 19 year: 2012 end-page: 1820 article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia publication-title: N Engl J Med – volume: 361 start-page: 1767 issue: 9371 year: 2003 end-page: 1772 article-title: Clinical progression and viral load in a community outbreak of coronavirus‐associated SARS pneumonia: a prospective study publication-title: Lancet – volume: 5 start-page: S103 issue: Suppl 2 year: 2013 end-page: 108 article-title: From SARS coronavirus to novel animal and human coronaviruses publication-title: J Thorac Dis – volume: 8 start-page: 122 issue: 1 year: 2006 end-page: 127 article-title: Role of vascular cell adhesion molecules and leukocyte apoptosis in the lymphopenia and thrombocytopenia of patients with severe acute respiratory syndrome (SARS) publication-title: Microbes Infect – volume: 76 start-page: 299 issue: 2 year: 2013 end-page: 315 article-title: Severity of the TGN1412 trial disaster cytokine storm correlated with IL‐2 release publication-title: Br J Clin Pharmacol – volume: 200 start-page: 282 issue: 3 year: 2003 end-page: 289 article-title: The clinical pathology of severe acute respiratory syndrome (SARS): a report from China publication-title: J Pathol – year: 2020 article-title: Kidney disease is associated with in‐hospital death of patients with COVID‐19 publication-title: Kidney Int – volume: 24 start-page: 3404 issue: 6 year: 2020 end-page: 3410 article-title: Clinical characteristics of 161 cases of corona virus disease 2019 (COVID‐19) in Changsha publication-title: Eur Rev Med Pharmacol Sci – volume: 278 start-page: 219 issue: 1 year: 2017 end-page: 236 article-title: Mechanisms of immune regulation in allergic diseases: the role of regulatory T and B cells publication-title: Immunol Rev – start-page: 1 year: 2020 end-page: 10 article-title: Can melatonin reduce the severity of COVID‐19 pandemic? publication-title: Int Rev Immunol – volume: 9 start-page: 727 issue: 1 year: 2020 end-page: 732 article-title: Hypothesis for potential pathogenesis of SARS‐CoV‐2 infection‐a review of immune changes in patients with viral pneumonia publication-title: Emerg Microbes Infect – volume: 323 start-page: 1061 issue: 11 year: 2020 article-title: Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus–infected pneumonia in Wuhan, China publication-title: JAMA – volume: 117 start-page: 9241 issue: 17 year: 2020 end-page: 9243 article-title: Phylogenetic network analysis of SARS‐CoV‐2 genomes publication-title: Proc Natl Acad Sci USA – volume: 49 start-page: 1 issue: 3 year: 2020 end-page: 9 article-title: Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID‐19 infection publication-title: Ann Acad Med Singapore – volume: 172 start-page: 4123 issue: 7 year: 2004 end-page: 4132 article-title: CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions publication-title: J Immunol – volume: 15 start-page: 511 issue: 8 year: 2015 end-page: 523 article-title: Eicosanoid storm in infection and inflammation publication-title: Nat Rev Immunol – year: 2020 article-title: Clinical features and treatment of COVID‐19 patients in Northeast Chongqing publication-title: J Med Virol – volume: 14 start-page: 350 issue: 4 year: 1984 end-page: 356 article-title: Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity publication-title: Eur J Immunol – volume: 579 start-page: 270 issue: 7798 year: 2020 end-page: 273 article-title: A pneumonia outbreak associated with a new coronavirus of probable bat origin publication-title: Nature – volume: 395 start-page: 507 issue: 10223 year: 2020 end-page: 513 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study publication-title: Lancet – volume: 63 start-page: 364 issue: 3 year: 2020 end-page: 374 article-title: Clinical and biochemical indexes from 2019‐nCoV infected patients linked to viral loads and lung injury publication-title: Sci China Life Sci – volume: 34 issue: 2 year: 2020 article-title: Induction of pro‐inflammatory cytokines (IL‐1 and IL‐6) and lung inflammation by Coronavirus‐19 (COVI‐19 or SARS‐CoV‐ 2): anti‐inflammatory strategies publication-title: J Biol Regul Homeost Agents – volume: 94 start-page: 1385 issue: 6 year: 2016 end-page: 1391 article-title: Lymphocytosis and lymphopenia induced by imported infectious diseases: a controlled cross‐sectional study of 17,229 diseased German travelers returning from the tropics and subtropics publication-title: Am J Trop Med Hyg – volume: 361 start-page: 304 issue: 2 year: 2007 end-page: 315 article-title: The intracellular sites of early replication and budding of SARS‐coronavirus publication-title: Virology – volume: 123 start-page: 735 issue: 4 year: 2009 end-page: 746 article-title: Mechanisms and treatment of allergic disease in the big picture of regulatory T cells publication-title: J Allergy Clin Immunol – volume: 75 start-page: 1699 year: 2020 end-page: 1709 article-title: Eleven faces of coronavirus disease 2019 publication-title: Allergy – year: 2020 article-title: Identification of kidney transplant recipients with Coronavirus disease 2019 publication-title: Eur Urol – volume: 59 start-page: E003 year: 2020 article-title: Characteristics of peripheral blood leukocyte differential counts in patients with COVID‐19 publication-title: Zhonghua Nei Ke Za Zhi – volume: 17 start-page: 259 issue: 5 year: 2020 end-page: 259 article-title: COVID‐19: faecal‐oral transmission? publication-title: Nat Rev Gastroenterol Hepatol – volume: 138 start-page: 575 issue: 5 year: 2020 article-title: Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID‐19) in Hubei Province, China publication-title: JAMA Ophthalmol – year: 2020 article-title: Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS‐coronavirus 2 publication-title: Science – year: 2020 article-title: Profiling early humoral response to diagnose novel Coronavirus disease (COVID‐19) publication-title: Clin Infect Dis – volume: 14 start-page: 1651 issue: 17–18 year: 1996 end-page: 1656 article-title: Antibody responses and protection in mice immunized orally against influenza virus publication-title: Vaccine – volume: 9 start-page: 678 year: 2018 article-title: The CD8 T cell response to respiratory virus infections publication-title: Front Immunol – volume: 74 start-page: 1832 issue: 10 year: 2019 end-page: 1834 article-title: Lung eosinophils‐A novel "virus sink" that is defective in asthma? publication-title: Allergy – volume: 75 start-page: 1071 year: 2020 end-page: 1018 article-title: Tolerance mechanisms of AIT publication-title: Allergy – year: 2020 article-title: Clinical features of 69 cases with Coronavirus disease 2019 in Wuhan, China publication-title: Clin Infect Dis – volume: 24 start-page: 91 issue: 1 year: 2020 article-title: Treatment of COVID‐19: old tricks for new challenges publication-title: Crit Care – volume: 505 start-page: 190 year: 2020 end-page: 191 article-title: Procalcitonin in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis publication-title: Clin Chim Acta – volume: 153 start-page: 725 issue: 6 year: 2020 end-page: 733 article-title: COVID‐19 autopsies, Oklahoma, USA publication-title: Am J Clin Pathol – volume: 52 start-page: 34 issue: 1 year: 2020 end-page: 41 article-title: COVID‐19 ‐ what should anaethesiologists and intensivists know about it? publication-title: Anaesthesiol Intensive Ther – year: 2020 article-title: Structure‐based design of antiviral drug candidates targeting the SARS‐CoV‐2 main protease publication-title: Science – volume: 8 start-page: 147 issue: 3 year: 2019 article-title: Contribution of resident memory CD8(+) T cells to protective immunity against respiratory syncytial virus and their impact on vaccine design publication-title: Pathogens – volume: 2 issue: 1 year: 2015 article-title: The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches publication-title: Austin J Vasc Med – volume: 13 start-page: 3 issue: 1 year: 2016 end-page: 10 article-title: The cytokine storm of severe influenza and development of immunomodulatory therapy publication-title: Cell Mol Immunol – volume: 27 start-page: 704 issue: 5 year: 2020 end-page: 709 article-title: Infection and rapid transmission of SARS‐CoV‐2 in ferrets publication-title: Cell Host Microbe – volume: 5 start-page: 33 year: 2020 article-title: Lymphopenia predicts disease severity of COVID‐19: a descriptive and predictive study publication-title: Signal Transduct Target Ther – year: 2020 article-title: Clinical characteristics of 25 death cases with COVID‐19: a retrospective review of medical records in a single medical center, Wuhan, China publication-title: Int J Infect Dis – year: 2020 article-title: Clinical predictors of mortality due to COVID‐19 based on an analysis of data of 150 patients from Wuhan, China publication-title: Intensive Care Med – volume: 382 start-page: 727 issue: 8 year: 2020 end-page: 733 article-title: A Novel Coronavirus from Patients with Pneumonia in China, 2019 publication-title: N Engl J Med – volume: 70 start-page: 3291 issue: Pt 12 year: 1989 end-page: 3296 article-title: Secretory immunoglobulin A antibody response is conserved in aged mice following oral immunization with influenza virus vaccine publication-title: J Gen Virol – volume: 95 start-page: 938 issue: 4 year: 2016 end-page: 944 article-title: Elevated Values of C‐reactive protein induced by imported infectious diseases: a controlled cross‐sectional study of 11,079 diseased german travelers returning from the tropics and subtropics publication-title: Am J Trop Med Hyg – volume: 368 start-page: m1091 year: 2020 article-title: Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study publication-title: BMJ – year: 2020 article-title: Spread of SARS‐CoV‐2 in the Icelandic Population publication-title: N Engl J Med – volume: 130 start-page: 1545 issue: 4 year: 2020 end-page: 1548 article-title: The convalescent sera option for containing COVID‐19 publication-title: J Clin Invest – volume: 323 start-page: 1406 issue: 14 year: 2020 article-title: Presumed asymptomatic carrier transmission of COVID‐19 publication-title: JAMA – volume: 110 start-page: 2987 issue: 8 year: 2013 end-page: 2992 article-title: Defective immunoregulation in RSV vaccine‐augmented viral lung disease restored by selective chemoattraction of regulatory T cells publication-title: Proc Natl Acad Sci USA – volume: 186 start-page: 652 issue: 3 year: 2016 end-page: 658 article-title: Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of middle east respiratory syndrome Coronavirus infection in the United Arab Emirates, April 2014 publication-title: Am J Pathol – volume: 12 start-page: 254 issue: 3 year: 2020 article-title: Preliminary identification of potential vaccine targets for the COVID‐19 Coronavirus (SARS‐CoV‐2) based on SARS‐ CoV immunological studies publication-title: Viruses – volume: 395 start-page: 497 issue: 10223 year: 2020 end-page: 506 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet – volume: 395 start-page: 1054 issue: 10229 year: 2020 end-page: 1062 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study publication-title: Lancet – volume: 323 start-page: 1582 issue: 16 year: 2020 article-title: Treatment of 5 s COVID‐19 with convalescent plasma publication-title: JAMA – year: 2020 article-title: A SARS‐CoV‐2 protein interaction map reveals targets for drug repurposing publication-title: Nature – volume: 119 start-page: 3266 issue: 11 year: 2009 end-page: 3277 article-title: Tregs control the development of symptomatic West Nile virus infection in humans and mice publication-title: J Clin Invest – year: 2020 article-title: Clinical features of 85 fatal cases of COVID‐19 from Wuhan: A retrospective observational study publication-title: Am J Respir Crit Care Med – year: 2020 article-title: The Greek study in the effects of colchicine in COvid‐19 complications prevention (GRECCO‐19 study): Rationale and study design publication-title: Hellenic J Cardiol – volume: 11 start-page: 1620 issue: 1 year: 2020 article-title: Characterization of spike glycoprotein of SARS‐CoV‐2 on virus entry and its immune cross‐reactivity with SARS‐CoV publication-title: Nat Commun – volume: 46 start-page: 379 issue: 03 year: 2020 end-page: 382 article-title: Recommendations for minimal laboratory testing panels in patients with COVID‐19: potential for prognostic monitoring publication-title: Semin Thromb Hemost – volume: 15 start-page: 17411 issue: 10 year: 2014 end-page: 17441 article-title: The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature publication-title: Int J Mol Sci – volume: 39 start-page: 529 issue: 5 year: 2017 end-page: 539 article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology publication-title: Semin Immunopathol – volume: 87 start-page: 641 issue: Pt 3 year: 2006 end-page: 650 article-title: Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus publication-title: J Gen Virol – volume: 323 start-page: 1612 issue: 16 year: 2020 article-title: Characteristics and Outcomes of 21 Critically Ill Patients With COVID‐19 in Washington State publication-title: JAMA – volume: 310 start-page: L532 issue: 6 year: 2016 end-page: 541 article-title: Cell‐free hemoglobin: a novel mediator of acute lung injury publication-title: Am J Physiol Lung Cell Mol Physiol – ident: e_1_2_16_8_1 doi: 10.1056/NEJMoa2006100 – ident: e_1_2_16_135_1 doi: 10.1016/j.cca.2020.03.004 – ident: e_1_2_16_10_1 doi: 10.1056/NEJMoa2002032 – ident: e_1_2_16_27_1 doi: 10.1080/08830185.2020.1756284 – ident: e_1_2_16_124_1 doi: 10.1016/S2213-2600(20)30127-2 – ident: e_1_2_16_9_1 doi: 10.1111/all.14289 – ident: e_1_2_16_63_1 doi: 10.1111/all.13811 – ident: e_1_2_16_26_1 doi: 10.1016/j.hjc.2020.03.002 – ident: e_1_2_16_40_1 doi: 10.4269/ajtmh.15-0920 – ident: e_1_2_16_123_1 doi: 10.1001/jama.2020.4914 – ident: e_1_2_16_96_1 doi: 10.1055/s-0040-1709498 – ident: e_1_2_16_49_1 doi: 10.1038/s41392-020-0148-4 – ident: e_1_2_16_56_1 doi: 10.1111/imr.12555 – ident: e_1_2_16_14_1 doi: 10.1001/jama.2020.0757 – ident: e_1_2_16_80_1 doi: 10.1016/S0264-410X(96)00128-4 – ident: e_1_2_16_94_1 doi: 10.1002/jmv.25783 – ident: e_1_2_16_71_1 doi: 10.1038/s41423-020-0401-3 – ident: e_1_2_16_105_1 doi: 10.1038/nri3859 – ident: e_1_2_16_98_1 doi: 10.1002/jmv.20255 – ident: e_1_2_16_109_1 doi: 10.1016/j.micinf.2012.10.008 – ident: e_1_2_16_132_1 doi: 10.1016/j.ijid.2020.03.053 – ident: e_1_2_16_31_1 doi: 10.1038/s41423-020-0498-4 – ident: e_1_2_16_146_1 doi: 10.1152/physrev.00013.2020 – ident: e_1_2_16_69_1 doi: 10.3390/pathogens8030147 – ident: e_1_2_16_19_1 doi: 10.1016/j.cell.2020.02.052 – ident: e_1_2_16_52_1 doi: 10.1080/22221751.2020.1736644 – ident: e_1_2_16_120_1 doi: 10.1001/jamainternmed.2020.0994 – ident: e_1_2_16_144_1 doi: 10.1093/cid/ciaa414 – ident: e_1_2_16_50_1 doi: 10.1111/all.14157 – ident: e_1_2_16_125_1 doi: 10.1001/jama.2020.4783 – ident: e_1_2_16_139_1 doi: 10.1002/ppul.24718 – ident: e_1_2_16_67_1 doi: 10.1093/ajcp/aqaa062 – volume: 38 start-page: 1 issue: 1 year: 2020 ident: e_1_2_16_112_1 article-title: Immune responses in COVID‐19 and potential vaccines: Lessons learned from SARS and MERS epidemic publication-title: Asian Pac J Allergy Immunol contributor: fullname: Prompetchara E – ident: e_1_2_16_58_1 doi: 10.4049/jimmunol.172.7.4123 – ident: e_1_2_16_11_1 doi: 10.1001/jama.2020.2565 – ident: e_1_2_16_97_1 doi: 10.1002/art.40071 – ident: e_1_2_16_111_1 doi: 10.1007/s00134-020-05991-x – ident: e_1_2_16_119_1 doi: 10.5114/ait.2020.93756 – ident: e_1_2_16_17_1 doi: 10.1038/s41586-020-2012-7 – ident: e_1_2_16_68_1 doi: 10.1038/s41423-020-0402-2 – volume: 24 start-page: 3404 issue: 6 year: 2020 ident: e_1_2_16_142_1 article-title: Clinical characteristics of 161 cases of corona virus disease 2019 (COVID‐19) in Changsha publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Zheng F – ident: e_1_2_16_2_1 doi: 10.1038/s41564-020-0695-z – ident: e_1_2_16_39_1 doi: 10.3390/v12030254 – ident: e_1_2_16_32_1 doi: 10.3390/ijms151017411 – ident: e_1_2_16_34_1 doi: 10.1016/j.jcv.2019.08.009 – ident: e_1_2_16_48_1 doi: 10.1016/j.jinf.2020.02.029 – ident: e_1_2_16_88_1 doi: 10.4269/ajtmh.16-0387 – ident: e_1_2_16_141_1 doi: 10.1016/j.eururo.2020.03.030 – ident: e_1_2_16_21_1 doi: 10.1038/s41467-020-15562-9 – ident: e_1_2_16_101_1 doi: 10.1128/mBio.00845-17 – ident: e_1_2_16_138_1 doi: 10.1001/jamaophthalmol.2020.1291 – ident: e_1_2_16_51_1 doi: 10.1292/jvms.18-0582 – ident: e_1_2_16_47_1 doi: 10.1001/jama.2020.1585 – volume: 2 issue: 1 year: 2015 ident: e_1_2_16_122_1 article-title: The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches publication-title: Austin J Vasc Med contributor: fullname: Gonzales JN – ident: e_1_2_16_70_1 doi: 10.3389/fimmu.2018.00678 – ident: e_1_2_16_79_1 doi: 10.1016/0264-410X(90)90250-P – ident: e_1_2_16_103_1 doi: 10.1093/infdis/jiv321 – volume: 5 start-page: S103 issue: 2 year: 2013 ident: e_1_2_16_3_1 article-title: From SARS coronavirus to novel animal and human coronaviruses publication-title: J Thorac Dis contributor: fullname: To KK – ident: e_1_2_16_83_1 doi: 10.1099/vir.0.81579-0 – ident: e_1_2_16_87_1 doi: 10.1016/j.abb.2019.07.013 – volume: 119 start-page: 3266 issue: 11 year: 2009 ident: e_1_2_16_61_1 article-title: Tregs control the development of symptomatic West Nile virus infection in humans and mice publication-title: J Clin Invest contributor: fullname: Lanteri MC – ident: e_1_2_16_133_1 doi: 10.1111/liv.14455 – volume: 34 issue: 2 year: 2020 ident: e_1_2_16_28_1 article-title: Induction of pro‐inflammatory cytokines (IL‐1 and IL‐6) and lung inflammation by Coronavirus‐19 (COVI‐19 or SARS‐CoV‐ 2): anti‐inflammatory strategies publication-title: J Biol Regul Homeost Agents contributor: fullname: Conti P – ident: e_1_2_16_137_1 doi: 10.1093/cid/ciaa538 – ident: e_1_2_16_131_1 doi: 10.7326/M20-0533 – ident: e_1_2_16_78_1 doi: 10.1002/eji.1830140414 – ident: e_1_2_16_25_1 doi: 10.1111/all.14345 – volume: 14 start-page: 39 issue: 4 year: 2008 ident: e_1_2_16_84_1 article-title: Studies of SARS virus vaccines publication-title: Hong Kong Med J contributor: fullname: Zheng BJ – ident: e_1_2_16_130_1 doi: 10.1016/j.jtho.2020.02.010 – ident: e_1_2_16_77_1 doi: 10.4049/jimmunol.173.3.1978 – ident: e_1_2_16_76_1 doi: 10.1016/S1473-3099(20)30196-1 – ident: e_1_2_16_41_1 doi: 10.1093/cid/ciaa248 – ident: e_1_2_16_65_1 doi: 10.1164/rccm.202003-0543OC – ident: e_1_2_16_43_1 doi: 10.1093/infdis/jiaa150 – ident: e_1_2_16_81_1 doi: 10.1099/0022-1317-70-12-3291 – ident: e_1_2_16_36_1 doi: 10.1111/all.14360 – ident: e_1_2_16_86_1 doi: 10.1093/cid/ciaa310 – ident: e_1_2_16_93_1 doi: 10.1002/jmv.25770 – ident: e_1_2_16_29_1 doi: 10.1038/s41586-020-2286-9 – ident: e_1_2_16_20_1 doi: 10.1126/science.abb7015 – ident: e_1_2_16_12_1 – ident: e_1_2_16_33_1 doi: 10.1007/s12015-020-09976-7 – ident: e_1_2_16_16_1 doi: 10.1111/all.14238 – ident: e_1_2_16_72_1 doi: 10.1172/JCI138003 – ident: e_1_2_16_115_1 doi: 10.1001/jama.2020.4326 – ident: e_1_2_16_18_1 doi: 10.1016/j.chom.2020.03.023 – ident: e_1_2_16_128_1 doi: 10.1016/j.ajpath.2015.10.024 – ident: e_1_2_16_82_1 doi: 10.1371/journal.pone.0220196 – ident: e_1_2_16_95_1 doi: 10.1136/bmj.m1091 – ident: e_1_2_16_117_1 doi: 10.1016/S2213-2600(20)30079-5 – ident: e_1_2_16_37_1 doi: 10.1016/j.chom.2020.03.002 – ident: e_1_2_16_66_1 doi: 10.1016/j.jaci.2020.04.021 – volume: 59 start-page: E003 year: 2020 ident: e_1_2_16_64_1 article-title: Characteristics of peripheral blood leukocyte differential counts in patients with COVID‐19 publication-title: Zhonghua Nei Ke Za Zhi contributor: fullname: Li YX – ident: e_1_2_16_23_1 doi: 10.1074/jbc.M109.008227 – ident: e_1_2_16_102_1 doi: 10.1111/bcp.12165 – volume: 4 issue: 5 year: 2015 ident: e_1_2_16_110_1 article-title: The role of C5a in acute lung injury induced by highly pathogenic viral infections publication-title: Emerg Microbes Infect contributor: fullname: Wang R – ident: e_1_2_16_145_1 doi: 10.1515/cclm-2020-0188 – ident: e_1_2_16_45_1 doi: 10.1007/s12519-020-00354-4 – ident: e_1_2_16_46_1 doi: 10.1016/S0140-6736(20)30183-5 – ident: e_1_2_16_4_1 doi: 10.1056/NEJMoa1211721 – ident: e_1_2_16_127_1 doi: 10.1002/path.1440 – ident: e_1_2_16_104_1 doi: 10.3389/fimmu.2018.03022 – ident: e_1_2_16_35_1 doi: 10.1038/s41591-020-0897-1 – ident: e_1_2_16_85_1 doi: 10.3201/eid2607.200841 – volume: 49 start-page: 1 issue: 3 year: 2020 ident: e_1_2_16_143_1 article-title: Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID‐19 infection publication-title: Ann Acad Med Singapore contributor: fullname: Goh KJ – ident: e_1_2_16_134_1 doi: 10.1097/CM9.0000000000000824 – ident: e_1_2_16_90_1 doi: 10.1016/j.jinf.2016.08.005 – ident: e_1_2_16_108_1 doi: 10.1080/22221751.2020.1747363 – ident: e_1_2_16_140_1 doi: 10.1172/JCI137244 – ident: e_1_2_16_74_1 doi: 10.1111/all.14126 – ident: e_1_2_16_106_1 doi: 10.1016/j.cell.2013.05.052 – ident: e_1_2_16_92_1 doi: 10.1016/S0140-6736(20)30566-3 – ident: e_1_2_16_57_1 doi: 10.1016/j.jaci.2009.02.030 – ident: e_1_2_16_15_1 doi: 10.1038/s41575-020-0295-7 – ident: e_1_2_16_60_1 doi: 10.1073/pnas.1217580110 – ident: e_1_2_16_30_1 doi: 10.1126/science.abb4489 – ident: e_1_2_16_100_1 doi: 10.1038/cmi.2015.74 – ident: e_1_2_16_114_1 doi: 10.1016/S0140-6736(03)13412-5 – ident: e_1_2_16_22_1 doi: 10.1016/j.virol.2006.11.027 – ident: e_1_2_16_42_1 doi: 10.1016/S2213-2600(20)30076-X – ident: e_1_2_16_99_1 doi: 10.1007/s00281-017-0629-x – ident: e_1_2_16_59_1 doi: 10.1111/all.14257 – ident: e_1_2_16_54_1 doi: 10.1002/jmv.25767 – ident: e_1_2_16_121_1 doi: 10.1152/ajplung.00155.2015 – ident: e_1_2_16_136_1 doi: 10.1016/j.kint.2020.03.005 – ident: e_1_2_16_24_1 doi: 10.1111/all.14344 – ident: e_1_2_16_75_1 doi: 10.1016/j.jinf.2020.04.019 – ident: e_1_2_16_13_1 doi: 10.1016/S1473-3099(20)30243-7 – ident: e_1_2_16_55_1 doi: 10.1038/s41577-020-0311-8 – ident: e_1_2_16_126_1 doi: 10.1111/aas.12034 – ident: e_1_2_16_38_1 doi: 10.1016/j.vaccine.2016.02.063 – ident: e_1_2_16_7_1 doi: 10.1073/pnas.2004999117 – ident: e_1_2_16_62_1 doi: 10.1089/vim.2018.0150 – ident: e_1_2_16_6_1 – ident: e_1_2_16_129_1 doi: 10.1136/jclinpath-2020-206522 – ident: e_1_2_16_116_1 doi: 10.1016/S0140-6736(20)30211-7 – ident: e_1_2_16_53_1 doi: 10.1016/j.micinf.2005.06.007 – ident: e_1_2_16_107_1 doi: 10.1007/s00281-017-0639-8 – ident: e_1_2_16_113_1 doi: 10.1001/jama.2017.21907 – ident: e_1_2_16_5_1 doi: 10.1056/NEJMoa2001017 – ident: e_1_2_16_44_1 doi: 10.1007/s11427-020-1643-8 – ident: e_1_2_16_91_1 doi: 10.1080/22221751.2020.1746199 – ident: e_1_2_16_73_1 doi: 10.1186/s13054-020-2818-6 – ident: e_1_2_16_89_1 doi: 10.3201/eid1005.030640 – ident: e_1_2_16_118_1 doi: 10.1002/jmv.25818 |
SSID | ssj0007290 |
Score | 2.7460823 |
SecondaryResourceType | review_article |
Snippet | As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of coronavirus... Abstract As a zoonotic disease that has already spread globally to several million human beings and possibly to domestic and wild animals, eradication of... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1564 |
SubjectTerms | Animals Antibodies, Viral - immunology Antiviral drugs Asymptomatic Autopsy Betacoronavirus - chemistry Betacoronavirus - immunology Cell activation Coronaviridae Coronavirus Infections - blood Coronavirus Infections - immunology Coronavirus Infections - virology Coronaviruses COVID-19 Cytokine storm Cytokines Cytokines - immunology Eosinopenia Eosinophils - immunology Epitopes, B-Lymphocyte - immunology Epitopes, T-Lymphocyte - immunology Herd immunity Humans immune response Immunity, Innate Immunoglobulin A Immunoglobulin G Immunoglobulin M immunologic tests Immunology immunopathology infections Lymphocytes - immunology Lymphocytes T Lymphopenia Medical personnel Occupational exposure pandemic Pandemics Patients Pneumonia, Viral - blood Pneumonia, Viral - immunology Pneumonia, Viral - virology Prevention Respiratory diseases Respiratory distress syndrome Review SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Vaccines Viral infections virus Zoonoses Zoonoses - immunology Zoonoses - virology |
Title | Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19 |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fall.14364 https://www.ncbi.nlm.nih.gov/pubmed/32396996 https://www.proquest.com/docview/2422434750 https://search.proquest.com/docview/2402425542 https://pubmed.ncbi.nlm.nih.gov/PMC7272948 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL1CLKpu-qCvtBS5VRfdBJHYiWOxGg0gqKCVoCAWSJHtuRajQlKRmU1XfEK_sV9SX-cBA0KquokixZYd28c-1773GOATd9YU0qoYCW5CuCQ2uZaxtDIx2QY65BScfPA13z0WX06z0yXY7GNhWn2IYcONkBHmawK4Ns0tkOuLCw9znpMWaMIluXNtHd5IR8luf8Xzh1h4VHeqQuTFM-RcXIvuEcz7fpK3-WtYgHaewllf9dbv5Mf6fGbW7a87qo7_-W_P4ElHTNmoHUnPYQmrFXh00B29v4CzPYokQXbVOtUim9XsaHR49Of697g-8c-U6WrCLpFCiafNZcNqx6aUp6Zbj_s5lrWRxg2bVmz87WRvy-dM1Es43tn-Pt6Nu6sZYkuKe3GhJS8kkli7r6aS2hMBk9ncWKswFTkqxAwLKW3hTTDUWWETZ6zjyuWO24y_guWqrvANsFRK41lfMpEOhdJGJ44Ly5OJ21BF5tIIPvadVP5sFTjK3nLx7VSGdopgte--sgNhU3r2kQouPCeK4MPw2cOHzkR0hfWc0gSjKxO-nNdtbw-l8JSr3NuDEciFcTAkIGnuxS_V9DxIdNPxthJFBJ9DNz9c8XK0vx9e3v570nfwOCWrPzgNr8Ly7GqO7z01mpm1gIG_SLQMlA |
link.rule.ids | 230,315,783,787,888,1378,27937,27938,46307,46731 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qRYJueFMCBQxiwSZVEztxLLEZTalmYKZIfakLUGR7rtVR2wR1ZjZd9RP4Rr4E37zoUCEhNlGk2LJj-9jn2vceA7zjzppMWhUiwU0IF4Um1TKUVkYm2UKHnIKTx7vp4FB8Ok6OV-BDGwtT60N0G26EjGq-JoDThvQ1lOuzM49znopbcNvDnRMst_d-i0fJZofFM4hQeFw3ukLkx9NlXV6NblDMm56S1xlstQTt3IdvbeVrz5PTzcXcbNrLP3Qd__fvHsC9hpuyXj2YHsIKFo_gzrg5fX8MX4cUTILsovarRTYv2X5vb__n1Y9-eeSfMdPFhJ0jRRNPZ-czVjo2pTwlXXzcTrOsDjaesWnB-l-Ohts-Z6SewOHOx4P-IGxuZwgtie6FmZY8k0h67b6aSmrPBUxiU2OtwlikqBATzKS0mbfCUCeZjZyxjiuXOm4T_hRWi7LAZ8BiKY0nftFEOhRKGx05LiyPJm5LZYmLA3jb9lL-vRbhyFvjxbdTXrVTABtt_-UNDme5JyCx4MLTogDedJ89guhYRBdYLihNZXclwpezXnd3VwqPuUq9SRiAXBoIXQJS517-UkxPKpVuOuFWIgvgfdXPf6943huNqpfn_570NdwdHIxH-Wi4-_kFrMW0CVD5EG_A6vxigS89U5qbVxUgfgHwBBCt |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL2iIKFuoPRBw6N1qy66CSKxE8diNRoYMe1AKyiIBVJke67VEZAgZmbDik_gG_mS2s6jTFGlqpsoUmzZsX3sc-17jwE-UaNVxrUI0cGNMROFKpU85JpHKtlGg9QFJx8cpvsn7MtZcjYHO00sTKUP0W64OWT4-doB_HpoHoFcXl5amNOUPYMFltqh6hjR0W_tKF5vsFgCETIL61pWyLnxtFlnF6MnDPOpo-RjAutXoN4ynDd1rxxPLramE7Wlb_-QdfzPn3sBSzUzJZ1qKK3AHBYvYfGgPnt_Bed9F0qC5KbyqkUyKclx5-j44e6-W57aZ0xkMSRX6GKJR-OrMSkNGbk8pbv2uJlkSRVqPCajgnS_nfZ3bc5IvIaT3t6P7n5Y380Qaie5F2aS04yjU2u31RRcWiagEp0qrQXGLEWBmGDGuc6sDYYyyXRklDZUmNRQndA3MF-UBb4FEnOuLO2LhtwgE1LJyFCmaTQ02yJLTBzAx6aT8utKgiNvTBfbTrlvpwA2mu7LaxSOc0s_YkaZJUUBfGg_W_y4QxFZYDl1abzVlTBbzmrV220pNKYitQZhAHxmHLQJnDb37Jdi9NNrdLvzbcGyAD77bv57xfPOYOBf1v496XtY_L7bywf9w6_r8Dx2OwDegXgD5ic3U9y0NGmi3nk4_AK-kg9c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immune+response+to+SARS-CoV-2+and+mechanisms+of+immunopathological+changes+in+COVID-19&rft.jtitle=Allergy+%28Copenhagen%29&rft.au=Azkur%2C+Ahmet+Kursat&rft.au=Akdis%2C+M%C3%BCbeccel&rft.au=Azkur%2C+Dilek&rft.au=Sokolowska%2C+Milena&rft.date=2020-07-01&rft.eissn=1398-9995&rft.volume=75&rft.issue=7&rft.spage=1564&rft_id=info:doi/10.1111%2Fall.14364&rft_id=info%3Apmid%2F32396996&rft.externalDocID=32396996 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-4538&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-4538&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-4538&client=summon |